Refine
Has Fulltext
- yes (342)
Is part of the Bibliography
- yes (342)
Year of publication
Document Type
- Journal article (289)
- Doctoral Thesis (46)
- Book article / Book chapter (2)
- Conference Proceeding (2)
- Review (2)
- Preprint (1)
Language
- English (342) (remove)
Keywords
- Infektionsbiologie (57)
- Escherichia coli (27)
- Candida albicans (17)
- escherichia coli (11)
- gene expression (11)
- RNA-seq (9)
- Immunologie (8)
- Staphylococcus aureus (8)
- expression (8)
- infection (8)
- Biologie (7)
- virulence (7)
- epithelial cells (6)
- gene regulation (6)
- identification (6)
- Malaria (5)
- RNA (5)
- Salmonella (5)
- activation (5)
- antimicrobial resistance (5)
- messenger RNA (5)
- plasmodium falciparum (5)
- sRNA (5)
- transcriptome (5)
- Dendritische Zelle (4)
- Genexpression (4)
- Hfq (4)
- Legionella pneumophila (4)
- Leishmania (4)
- Leishmania major (4)
- Neisseria meningitidis (4)
- antibiotics (4)
- antibodies (4)
- antisense RNA (4)
- bacteria (4)
- biofilms (4)
- inhibition (4)
- pathogens (4)
- resistance (4)
- small RNA (4)
- synthesis (4)
- transcriptomics (4)
- vancomycin (4)
- Aspergillus fumigatus (3)
- Campylobacter jejuni (3)
- Enterobacteriaceae (3)
- Evolution (3)
- Expression (3)
- Genregulation (3)
- Grad-seq (3)
- Pathogenität (3)
- RNA sequencing (3)
- RNA-binding proteins (3)
- RNS (3)
- Salmonella Typhimurium (3)
- Salmonella enterica (3)
- Salmonella typhimurium (3)
- Small RNA (3)
- adaptation (3)
- antibacterial activity (3)
- autophagy (3)
- bacillus subtilis (3)
- biology (3)
- cancer (3)
- genes (3)
- genome sequence (3)
- leishmania major (3)
- leishmaniasis (3)
- macrophages (3)
- malaria (3)
- mechanisms (3)
- medicine (3)
- mouse models (3)
- protein kinase (3)
- regulatory RNA (3)
- riboswitch (3)
- sequence (3)
- signaling pathway (3)
- staphylococcus aureus (3)
- stem cells (3)
- substituent (3)
- transcription (3)
- transcription factors (3)
- translation (3)
- transmission (3)
- virulence factors (3)
- 3D tissue model (2)
- Agent (2)
- Antisense RNA (2)
- Bacteria (2)
- Bakterien (2)
- Biofilm (2)
- Breast-tumors (2)
- COVID-19 (2)
- Cancer (2)
- Candida auris (2)
- DNA transcription (2)
- E. coli serotype 06 (2)
- F8 fimbriae (2)
- Fluconazole (2)
- Genanalyse (2)
- Gene regulation (2)
- Growth (2)
- HFQ (2)
- HeLa cells (2)
- Helicobacter pylori (2)
- Immunsystem (2)
- Impfung (2)
- In-vivo (2)
- Infection (2)
- Infektion (2)
- Integrine (2)
- Lung cancer (2)
- MATQ-seq (2)
- Medizin (2)
- Nude-mice (2)
- Pathogens (2)
- Plasmodium falciparum (2)
- RNA synthesis (2)
- Rhodobacter sphaeroides (2)
- SARS-CoV-2 (2)
- SEQ (2)
- Salmonellosis (2)
- Schwamm (2)
- Shigella (2)
- Stickstoff (2)
- Streptococcus pneumoniae (2)
- Streptomyces (2)
- Therapy (2)
- TraDIS (2)
- UTI (2)
- Virulenz (2)
- Virulenzfaktor (2)
- adhesion (2)
- allelic replacement (2)
- antibiotic resistance (2)
- antifungals (2)
- antigen (2)
- antisense RNAs (2)
- apoptosis (2)
- archaea (2)
- bacterial genetics (2)
- bioluminescence imaging (2)
- biosynthesis (2)
- candida albicans (2)
- cell wall (2)
- chaperone (2)
- comparative genomics (2)
- cytokines (2)
- cytotoxicity (2)
- dRNA-Seq (2)
- dendritic cells (2)
- enterica serovar typhimurium (2)
- epidemiology (2)
- evolution (2)
- fluorescence microscopy (2)
- gametocyte (2)
- gastric cancer (2)
- gastrointestinal tract (2)
- gene (2)
- gene cloning (2)
- gene expression profiling (2)
- genome (2)
- genome annotation (2)
- glycopeptide antibiotics (2)
- hemolysin (2)
- host cells (2)
- in vitro (2)
- in vivo imaging (2)
- in-vitro (2)
- in-vivo (2)
- inflammation (2)
- inhibitor (2)
- liraglutide (2)
- magnetic resonance imaging (2)
- mechanism (2)
- messenger-RNA (2)
- metabolism (2)
- metastasis (2)
- methionine (2)
- mutation (2)
- ncRNA (2)
- neuroimmunology (2)
- neutrophils (2)
- noncoding RNA (2)
- obesity (2)
- oncolytic virotherapy (2)
- oncolytic viruses (2)
- parasitic diseases (2)
- pathogenicity (2)
- phylogeny (2)
- plants (2)
- polycationic peptides (2)
- proteasome (2)
- protein kinases (2)
- proteins (2)
- recombination (2)
- red fluorescent protein (2)
- regulator (2)
- regulator genes (2)
- response regulator (2)
- responses (2)
- ribonucleases (2)
- secretion (2)
- secretion systems (2)
- signal transduction (2)
- single-cell RNA-seq (2)
- small RNAs (2)
- small nucleolar RNAs (2)
- strains (2)
- structure-activity (2)
- subunit (2)
- therapy (2)
- transmission electron microscopy (2)
- tumors (2)
- type VII secretion system (2)
- vaccinia virus (2)
- (+)-limonene (1)
- (Nucleotide sequence (1)
- 0 antigen (1)
- 2-component system (1)
- 3D Gewebemodelle (1)
- 3D cell culture (1)
- 3′ UTR (1)
- 5-bromodeoxyuridine (1)
- 6S RNA (1)
- AAV vector (1)
- AMP-activated kinases (1)
- APEC (1)
- ATG (1)
- ATG8 (1)
- AcrAB-TolC efflux pump (1)
- Adaptorproteine (1)
- Adherence (1)
- Adhesion (1)
- Adhäsion (1)
- Alkyltransferase Ribozyme SAMURI (1)
- Angeborene Immunität (1)
- Anopheles stephensi (1)
- Antigenpräsentation (1)
- Antimicrobial activity (1)
- Apicomplexan (1)
- Archaea (1)
- Arzneimitteldesign (1)
- Asthma (1)
- Asymptomatic Bacteriuria (1)
- Autotransporter (1)
- Avirulent Salmonella (1)
- BCG (1)
- BNIP3 (1)
- BT_1884 (1)
- Bacillus subtilis (1)
- Bacterial conjugation (1)
- Bacterial infection (1)
- Bacterial pathogens (1)
- Bacteriaophage AR9 (1)
- Bakterielle Infektion (1)
- Biofilm formation (1)
- Bioinformatics (1)
- Biology (1)
- Blood-brain barrier (1)
- Blutgefäß (1)
- Bordeiella pertussis (1)
- Bovine Mastitis (1)
- Bovis (1)
- Bradyrhizobium (1)
- Bronchialasthma (1)
- C-6-H (1)
- C-Terminus (1)
- CEACAM3 (1)
- COX-2 (1)
- CRISPR-Cas system (1)
- CRISPRs (1)
- CTSE (1)
- CUL4-DDB1 ubiquitin ligase (1)
- Calcium (1)
- Carcino-embryonales Antigen (1)
- Carcinoma (1)
- Cas9 (1)
- Cell binding (1)
- Characterization (1)
- Chemical modification (1)
- Chemotherapy (1)
- Chlamydia (1)
- Chlamydia pneumoniae (1)
- Chlamydien (1)
- Chlamydophila pneumoniae (1)
- Combination therapy (1)
- Complexome (1)
- CpG (1)
- Crohns-disease (1)
- CsrA (1)
- Cutaneous leishmaniasis (1)
- Cyanobacteria (1)
- Cyanobakterien (1)
- Cyclophosphamide (1)
- Cystic-fibriosis (1)
- DASH (1)
- DNA (1)
- DNA glycosation (1)
- DNA lang range mapping (1)
- DNA methylation (1)
- DNA methylferase homolog (1)
- Defensine (1)
- Deletion (1)
- Denaturierende Gradienten-Gelelektrophorese (1)
- Denaturing Gradient Gel Electrophoresis (1)
- Dendritic cell (1)
- Dendritic cells (1)
- Dendrtitischer Zellen (1)
- Dextran sulphate (1)
- Diarrhea (1)
- Disease gene prioritization (1)
- Division (1)
- Drug resistance (1)
- Dual 3'seq (1)
- Dual RNA-seq (1)
- E. coli Nissle 1917 (1)
- E. coli hemolysin (1)
- E. coli virulence (1)
- ECM (1)
- EGFP (1)
- ESAT‐6‐like secretion system (1)
- ESS (1)
- EZM (1)
- Efflux pump (1)
- Eingeweidewürmer (1)
- Eisen (1)
- Eisenmangel (1)
- Elektronisches Publizieren (1)
- Elektroporation (1)
- Enterica serovar typhimurium (1)
- Enterococcus faecalis (1)
- Enterococcus faecium (1)
- Environmental isolate (1)
- Epstein-Barr virus (1)
- Erwachsener (1)
- Erwinia amylovora (1)
- EsaA (1)
- Escherichia coli-Hfq (1)
- Escherichia-coli K-12 (1)
- Ethiopia (1)
- ExPEC (1)
- Excision (1)
- Extracellular matrix (1)
- F-19 MRI (1)
- F1 (1)
- FAK (1)
- Factor H (1)
- Family (1)
- Fimbria (1)
- Fimbriae (1)
- FinO family (1)
- Fitness (1)
- Fluconazol (1)
- Foc protein (1)
- Ftsz (1)
- Fusobacterium nucleatum (1)
- GFP (1)
- GI-101A tumor xenografts (1)
- GLP-1 (1)
- GLV-1 h153 (1)
- GLV-1H68 (1)
- GO1 (1)
- Gametozyt (1)
- Gene (1)
- Gene cloning (1)
- Gene expression (1)
- Gene mapping (1)
- Gene-expression (1)
- Gene-transfer (1)
- Genetik (1)
- Genome analysis (1)
- Genome re-annotation (1)
- Genomic profile (1)
- Genomik (1)
- Genomorganisation (1)
- Germany (1)
- GibS (1)
- Gifsy-1 (1)
- Glatte Muskulatur (1)
- Gram-positive bacteria (1)
- Grundsubstanz (1)
- H-NS (1)
- HBD2 (1)
- HD5 (1)
- HIV (1)
- Haemolysin (1)
- Haloferax volcanii (1)
- Harnwegsinfekt (1)
- Helicobacterpylori (1)
- Helminthen (1)
- Helminths (1)
- Hemolysin excretion (1)
- Herzmuskel (1)
- Hidden-Markov-Modell (1)
- Hirnhautentzündung (1)
- Histatin 5 (1)
- Histon-ähnliche Proteine (1)
- Histone-like proteins (1)
- Homology (1)
- Hospital water system (1)
- Hospitalismus <Hygiene> (1)
- Host adaptation (1)
- Host cells (1)
- Human-pathogenic (1)
- Hämolysin (1)
- IL-12 production (1)
- IL-4 (1)
- IL-4 Rezeptor alpha (1)
- IL-4 receptor alpha chain (1)
- ITAM (1)
- IcaR (1)
- Ileal Crohns-disease (1)
- Images (1)
- Immunbiologie (1)
- Immunisierung (1)
- Immunohistochemistry; Immunogold-silver staining; FITC- anti-FITC system; Leucocyte subpopulations; Two-color staining (1)
- Immunotherapy (1)
- Immunreaktion (1)
- Impfstoff (1)
- Impfungen (1)
- In-vitro (1)
- Inactivation (1)
- Infection models (1)
- Inflammation (1)
- Inhibitor (1)
- Integrin (1)
- Interferon <gamma-> (1)
- Interleukin 12 (1)
- Internal transcription start site (1)
- Invasion genes (1)
- Ire1 (1)
- Iron-oxide (1)
- Iron-uptake (1)
- Isolation and Characterization (1)
- IsrK (1)
- K279a (1)
- Kapsel (1)
- KhpB protein (1)
- Kinase (1)
- Kinasen (1)
- Klebsiella pneumoniae (1)
- Kleine Proteine (1)
- Koevolution (1)
- Krankheitsübertragung (1)
- Krebs <Medizin> (1)
- Langerhans cell (1)
- Leaderless transcript (1)
- Legionella ssp. (1)
- Legionellae (1)
- Leishmaniose (1)
- Lesions (1)
- Level (1)
- Library of Phytochemicals (1)
- Library of plant species (1)
- Listeria monocytogenes (1)
- Lungenkrebs (1)
- Lysis (medicine) (1)
- MACE (1)
- MDR1 (1)
- MET-T-box riboswitch (1)
- MI-2/NURD complex (1)
- MITE (1)
- MRI reporter (1)
- MRR1 (1)
- MRSA (1)
- MRSA - methicillin-resistant Staphylococcus aureus (1)
- MTOR (1)
- MVT (1)
- Macrophage (1)
- Maintenance (1)
- Makrophage (1)
- Malariamücke (1)
- Malignant effusion (1)
- Mat Fimbrien (1)
- Mat fimbriae (1)
- Medicine (1)
- Medizinische Mikrobiologie (1)
- Meeresschwämme (1)
- Methanosarcina mazei (1)
- Methioninbiosynthese (1)
- MgrB (1)
- MicF (1)
- Mice (1)
- MicroRNAs (1)
- Microarray (1)
- Microscopy (1)
- Microwave Assisted Extraction (1)
- Mig1 (1)
- Mikroarray (1)
- Mikroskopie (1)
- Minor subunits (1)
- Mitteldarm (1)
- Molekulare Infektionsbiologie (1)
- Molekulargenetik (1)
- Mosquito (1)
- Mouse (1)
- Mrr1 (1)
- Multidrugresistant (1)
- Multiproteinkomplex (1)
- Mutant (1)
- Mycobacterium (1)
- Mäuse (1)
- Mücke (1)
- N-glycans (1)
- NAFLD (1)
- NAS (1)
- NASH (1)
- ND10 complex (1)
- NF-KAPPA-B (1)
- NK cells (1)
- NOTCH (1)
- NRG1 (1)
- NSG (1)
- Nature-Insipired Synthesis (1)
- Nck (1)
- Neisseria gonorrhoeae (1)
- Neugeborenes (1)
- Nichtrezeptor-Tyrosinkinasen (1)
- Nitrogen (1)
- Nodule (1)
- Non-coding RNA (1)
- Non-coding RNAs (1)
- Nonpathogenic Escherichia-coli (1)
- Nosocomial Infections (1)
- Nosokomiale Infektionen (1)
- OLFM4 (1)
- Oberflächenproteine der Sexualstadien (1)
- Oncolytic virotherapy (1)
- One Health (1)
- Open Science (1)
- Organoids (1)
- Orthogonal field attenuation gel electrophoresis (1)
- OxyR (1)
- P-fimbriae (1)
- P. falciparum (1)
- PCR (1)
- PEGylation (1)
- PETRI-seq (1)
- PFS25 (1)
- PIA/ica (1)
- PML (1)
- PML nuclear-bodies (1)
- PPGPP (1)
- PSI-blast (1)
- PYY3-36 (1)
- Paeonia (1)
- Pan1 (1)
- Parkinson's disease (1)
- Particles (1)
- Pathogene Bakterien (1)
- Pathogenicity (1)
- Pathogenitätsinseln (1)
- Pathologie (1)
- Pathology (1)
- PfAMA1 (1)
- PfCCp protein (1)
- Pflanzen (1)
- Pfs230 (1)
- Phagozytose (1)
- Pilus (1)
- PknB (1)
- Plant extracts (1)
- Plants (1)
- Plasmid (1)
- Polymeric Immunoglobulin receptor (1)
- Polysaccharide intercellular adhesin (PIA) (1)
- Porifera (1)
- ProQ (1)
- Probiotic (1)
- Probiotikum (1)
- Promoter (1)
- Promoter prediction (1)
- Proteasen (1)
- Protein (1)
- Protein function prediction (1)
- Proteine (1)
- Proteins (1)
- Proteogenomics (1)
- Proteomanalyse (1)
- Pseudomonas (1)
- Pseudomonas aeruginosa (1)
- Pseudomonas-aeruginosa (1)
- RFP (1)
- RNA Abbau (1)
- RNA CHAPERONE HFQ (1)
- RNA chaperone Hfq (1)
- RNA decay (1)
- RNA denaturation (1)
- RNA expression (1)
- RNA sequence analyses (1)
- RNA structure (1)
- RNA-Seq (1)
- RNA-binding protein (1)
- RNA-polymerase-I (1)
- RNA-polymerase-II (1)
- RNA-sequencing (1)
- RNAseq (1)
- RNS-Bindungsproteine (1)
- RNS-Spleißen (1)
- RNase E (1)
- RNase III (1)
- ROS (1)
- RTS,S/AS01 malaria vaccine (1)
- RYGB (1)
- Rapid evolution (1)
- Rats (1)
- Recombinant defensins (1)
- Recombinant vaccinia (1)
- Recombination directionality factor (1)
- Regression (1)
- Regulation (1)
- Rekombinante DNS (1)
- RelA (1)
- Reproducibility challenges (1)
- Resistance (1)
- Resistenz (1)
- Restenose (1)
- Ribosome profiling (1)
- Roux-en-Y gastric bypass surgery (1)
- S fimbrial adhesin (Sfa) (1)
- S-Fimbriae (1)
- S-fimbria (1)
- S-fimbriae (1)
- S. aureus (1)
- SAP2 (1)
- SER/THR kinase (1)
- SM-like protein (1)
- SNF1 (1)
- STEC (1)
- STP1 (1)
- SUBSP carotovora (1)
- SWI2/SNF2-like protein (1)
- Salmonella enterica Typhimurium strain SL1344 (1)
- Salmonella-enteritidis (1)
- Salmonella-typhimurium (1)
- Schistosoma japonicum; Egg antigen; Carbohydrate epitope; Circumoval precipitin test; Immunoassay (1)
- SdsR (1)
- Secretion (1)
- Sequence Analysis (1)
- Sequence identity (1)
- Sequencing (1)
- Sequenzanalyse (1)
- Serogroup (1)
- Serratia marcescens (1)
- Sexuelle Entwicklung (1)
- Shiga toxin-producing Escherichia coli (1)
- Shigellosis (1)
- Signalkette (1)
- Signaltransduktion (1)
- Site-specific RNA labelling (1)
- Snf1 (1)
- Soft-tissue infection (1)
- Southern hybridization (1)
- Speichel (1)
- Splicing (1)
- Sponge diseases (1)
- Src-Proteine (1)
- Staphylococcal infection (1)
- Staphylococcus (1)
- Staphylococcus aureus USA300 (1)
- Staphylococcus epidermidis (1)
- Staphylococcus-aureus (1)
- Stenotrophomonas maltophilia (1)
- Stickstoffmetabolismus (1)
- Stickstoffwechsel (1)
- Stp (1)
- StpA (1)
- Strain nissle-1917 (1)
- Strains (1)
- Stringent response (1)
- Stringente Antwort (1)
- Stringente Kontrolle (1)
- Sugar-transport (1)
- Suicide vector (1)
- SuperSAGE (1)
- Symbionts (1)
- Symbiose (1)
- Synthese (1)
- Synthesis (1)
- T cell (1)
- T cells (1)
- T helper cell (1)
- T lymphocytes (1)
- T-cell (1)
- TEM (1)
- TH1/TH2 (1)
- TRNA(ASP) (1)
- Th1 immunantwort (1)
- Th1 response (1)
- Thiostrepton (1)
- Tissue (1)
- Tissue Engineering (1)
- Toll-like receptors (1)
- Toxicity ; plasmids (1)
- Toxoplasma gondii (1)
- Tracking (1)
- Transcription (1)
- Transcription profiling (1)
- Transcription start site (1)
- Transcriptome (1)
- Transcriptome analysis (1)
- Transfektion (1)
- Transfer-RNA modification (1)
- Transkiptom (1)
- Transkription <Genetik> (1)
- Transkriptionsfaktor (1)
- Transkriptom (1)
- Transkriptomanalyse (1)
- Translation efficiency (1)
- Transmissionsblockierende Impfstoffe (1)
- Transposon (1)
- Transposon insertion sequencing (1)
- Typhimurium (1)
- UKZ (1)
- UME6 (1)
- UPEC (1)
- UPECs (1)
- Urinary tract (1)
- Urogenitalsystem (1)
- Uropatbcgenie E. coli (1)
- VEGF (1)
- Vaccines (1)
- Vaccinia virus (1)
- Vakuole (1)
- Valeriana wallichii (1)
- Variability (1)
- Variants (1)
- Vascular endothelial Growth Factor (1)
- Vertikale Weitergabe (1)
- Virologie (1)
- Virtual Research Environment (1)
- Virulence (1)
- Virusinfektion (1)
- WD40 (1)
- Wirtszelle (1)
- Yeast (1)
- Yersinia (1)
- Yersinia-pseudotuberculosis (1)
- YoelII-Nigeriensis (1)
- Ypk1 (1)
- Zoonotisches Risiko (1)
- abscesses (1)
- acetivorans C2A (1)
- acetones (1)
- acid (1)
- acrican trypanosomes (1)
- actinomycetes (1)
- activation mechanism (1)
- acute myeloid leukemia (1)
- adaptation phase (1)
- adults (1)
- agroinfiltration (1)
- alignment (1)
- alignment clustering (1)
- alpha defensins (1)
- alternative pig farming (1)
- alveolar fibrosis (1)
- alveolar regeneration (1)
- ammonium (1)
- ammonium permease (1)
- animal model (1)
- animal models (1)
- animal-model (1)
- annotation (1)
- anti-biofilm (1)
- anti-schistosomal activity (1)
- anti-sigma factor (1)
- antibacterial (1)
- antibacterial drug resistance (1)
- antibacterials (1)
- antibiotic (1)
- antibiotic production (1)
- antifungal drug (1)
- antigen-presenting cells (1)
- antigenic variation (1)
- antimicrobial activity (1)
- antimicrobial peptides (1)
- antitermination (1)
- arabidopsis (1)
- aspergillosis (1)
- aspergillus fumigatus (1)
- atypical tetracyclines (1)
- automation (1)
- autophagy-related (1)
- autotransporter (1)
- azobenzenes (1)
- bac-genomics-scripts (1)
- bacterial biofilms (1)
- bacterial genomes (1)
- bacterial genomics (1)
- bacterial immune evasion (1)
- bacterial infection (1)
- bacterial infection model (1)
- bacterial lipoproteins (1)
- bacterial migration (1)
- bacterial pathogen (1)
- bacterial resistance (1)
- bacterial secretion (1)
- bacterial signal molecule (1)
- bacterial transcription (1)
- bacterial virulence (1)
- bacteriophage (1)
- balancing selection (1)
- beta-glucuronidase (1)
- beta-lactamases (1)
- binding (1)
- binding protein HFQ (1)
- biocide polyhexamethylene biguanide (1)
- biofilm (1)
- biofilm regulation (1)
- biolog (1)
- biological scaffold (1)
- bioluminescence (1)
- bioorthogonal SAM analogue ProSeDMA (1)
- biophotonic imaging (1)
- biosynthetic gene-cluster (1)
- blood (1)
- blood-brain barrier (1)
- blood-cerebrospinal fluid barrier (1)
- blood-stream forms (1)
- brain endothelial cells (1)
- breast-tumors (1)
- broad-spectrum antibiotics (1)
- burkholderia cenocepacia (1)
- caffeic acid bornyl ester (1)
- campestris PV vesicatoria (1)
- campylobacter (1)
- cancer microenvironment (1)
- cancer treatment (1)
- cancers and neoplasms (1)
- candida (1)
- capsule (1)
- carbon metabolism (1)
- carcinoma (1)
- carcinomas (1)
- cardiac remodeling (1)
- carvacrol (1)
- casposon (1)
- catalytic (1)
- cell cultures (1)
- cell cycle (1)
- cell death (1)
- cell differentiation (1)
- cell fusion (1)
- cell signalling (1)
- cell vaccines (1)
- cell wall synthesis (1)
- cell-cycle arrest (1)
- cell-line (1)
- cepedia complex (1)
- chaperone HFQ (1)
- chaperone Hfq (1)
- characterization (1)
- chelocardins (1)
- children (1)
- chlamydomonas flagella (1)
- chromosomal genes (1)
- citral (1)
- citrus (1)
- clinical (1)
- clinical isolates (1)
- clonal analysis (1)
- co-infection (1)
- coagulase-negative staphylococci (1)
- coevolution (1)
- cold-shock protein (1)
- coli nissel 1917 (1)
- collaboratories (1)
- colony morphotypes (1)
- colorectal (1)
- colorectal cancer (1)
- community settings (1)
- comparative sequence analysis (1)
- complete genome sequence (1)
- complex (1)
- components (1)
- conditional mutants (1)
- conditional promoter replacement (1)
- conservation (1)
- conserving surgery (1)
- consesus (1)
- contact lens (1)
- cost-effectiveness (1)
- crystal structure (1)
- crystal-structures (1)
- cytolethal distending toxin (1)
- dRNA-seq (1)
- dark-matter (1)
- database (1)
- decay (1)
- deep sequencing (1)
- deepSuperSAGE (1)
- deficient mice (1)
- deletion mutagenesis (1)
- dependent gene-expression (1)
- dependent protein-kinase (1)
- derivatives (1)
- determines pathgenicity (1)
- diagnostic Microarray (1)
- diagnostischer Microarray (1)
- diarrhea (1)
- differential (1)
- directional RNA-Seq (1)
- disease (1)
- diseases of the nervous system (1)
- dogs (1)
- domain (1)
- domain genes A3(2) (1)
- down regulation (1)
- drospophila (1)
- drug (1)
- drug design (1)
- drug resistance evolution (1)
- drug-delivery systems (1)
- dual RNA-seq (1)
- dual function (1)
- dynamic programming (1)
- ecoli_VF_collection (1)
- eigenvector centrality (1)
- electron tomography (1)
- electrophilic stress (1)
- elements (1)
- emotional behavior (1)
- emulsions (1)
- endocytosis (1)
- endoribonuclease (1)
- energy metabolism (1)
- enteric pathogens (1)
- enterica serovar thphimurium (1)
- entero-aggregative-haemorrhagic Escherichia coli (EAHEC) (1)
- enterobacteria (1)
- enterococci (1)
- environment (1)
- environmental regulation (1)
- enzyme APOBEC3G (1)
- enzyme-linked immunoassays (1)
- ephitelial cells (1)
- epithelial-mesenchymal transition (1)
- epithelium (1)
- escherichia coli K-12 (1)
- essential gene (1)
- essential genes (1)
- essential oils (1)
- ethanol (1)
- eugenyl cinnamate (1)
- eukaryotes (1)
- experimental visceral leishmaniasis (1)
- expression mutants (1)
- extracellular domain (1)
- extracellular enzymes (1)
- extraintestinal E. coli (1)
- extraintestinal isolates (1)
- extrapulmonary (1)
- falciparum (1)
- family (1)
- fatty acids (1)
- fibronectin-binding protein (1)
- filamentous Salmonella Typhimurium (1)
- finder using symmetrical best hits (1)
- flagellar basal body (1)
- flagellum (1)
- flotillin (1)
- flow cytometry (1)
- fluconazole resistance (1)
- fluorescence imaging (1)
- fluorescent probe (1)
- fluorescent protein (1)
- flux balance analysis (1)
- food industry (1)
- functional genomics (1)
- fungal genetics (1)
- fungal pathogens (1)
- fungi (1)
- fungus (1)
- gallotannins (1)
- gamete (1)
- gametes (1)
- gastric bypass (1)
- gastrointestinal disease (1)
- gastrointestinal infections (1)
- gene expression heterogeneity (1)
- gene family targeting (1)
- gene probes (1)
- gene therapy (1)
- gene-cloning (1)
- gene-cluster (1)
- gene-expression (1)
- general stress response (1)
- genetic modification (1)
- genetic organization (1)
- genetic recombination (1)
- genetic transcription (1)
- genome organization (1)
- genome wide (1)
- genome-wide analysis (1)
- genomes (1)
- genomic deletions (1)
- genomic islands (1)
- genomic libraries (1)
- genomic library construction (1)
- genomics (1)
- genus Aspergillus (1)
- geometry (1)
- germination (1)
- global gene expression (1)
- glv-1h68 (1)
- glycolysis (1)
- glycosome (1)
- glycosyl phosphatidyl-inostitols. (1)
- gonococci (1)
- gram-negative bacteria (1)
- green fluorescent protein (1)
- growth (1)
- growth rate control (1)
- haemoproteus-columbae (1)
- halstedii JM8 (1)
- harmonia axyridis (1)
- harmonine (1)
- hela cells (1)
- helicobacter (1)
- hemolytic-uremic syndrome (1)
- heterogeneity (1)
- heterologous production (1)
- heteropathogenicity (1)
- hexose transporter (1)
- hidden markov-models (1)
- high-throughput sequencing (1)
- histidine kinases (1)
- histology (1)
- homologs (1)
- homology search (1)
- horizontal gene transfer (1)
- hos tcells (1)
- host (1)
- host (organism) (1)
- host colonization (1)
- host pathogen interaction (1)
- host-cell invasion (1)
- host-pathogen-interaction (1)
- human factor H (1)
- human herpesvirus 6 (1)
- human macrophages (1)
- human pathogenic fungi (1)
- human pathogens (1)
- human sodium iodide symporter (hNIS) (1)
- humaner Faktor H (1)
- humanized mice (1)
- hybrid (1)
- hydrogen regulation (1)
- hydrogen-peroxide (1)
- hyperexpression techniques (1)
- hypersensitive response (1)
- hyperthermophile (1)
- hyphae (1)
- hypothalamic gene expression (1)
- icaADBC (1)
- immune response (1)
- immune sytem (1)
- immunity (1)
- immunization (1)
- immunodeficiency-virus type-1 (1)
- in vivo (1)
- in-vitro propagation (1)
- inactivation (1)
- infection biology (1)
- infectious disease (1)
- inflammatory bowel disease (1)
- inflammatory-bowel-disease (1)
- inhibitors (1)
- insect immunity (1)
- insights (1)
- integration (1)
- interaction surfaces (1)
- interactome (1)
- interferon-gamma (1)
- intermediate host (1)
- internalization (1)
- intervention strategies (1)
- interview (1)
- intestinal enteroids (1)
- intracellular pathogen (1)
- intracellular pathogens (1)
- invasion (1)
- iron (1)
- iron limitation (1)
- island (1)
- isolation (1)
- kinase (1)
- kingdom (1)
- latency (1)
- lead structure (1)
- leaves (1)
- legionella pneumophila (1)
- leishmania (1)
- leishmaniose (1)
- libraries (1)
- library screening (1)
- life cycle (1)
- lines (1)
- linker influence (1)
- lipids (1)
- liquid chromatography-mass spectrometry (1)
- listeria monocytogenes (1)
- livestock-associated staphylococci (1)
- locus (1)
- luciferase (1)
- lux (1)
- lymph nodes (1)
- lymphadenitis (1)
- lytic replication (1)
- mC (1)
- mCherry (1)
- macrophage infection (1)
- malaria parasite (1)
- malaria vaccine (1)
- maps (1)
- marine sponges (1)
- mass spectrometry (1)
- mastectomy (1)
- mastitis-associated Escherichia coli (MAEC) (1)
- maternal separation (1)
- mating (1)
- maturation (1)
- mechanism of resistance (1)
- mechanisms of disease (1)
- membrane (1)
- membrane proteins (1)
- membrane vesicles (1)
- membrane-protein topology (1)
- meningococcus (1)
- merozoite (1)
- messanger RNA (1)
- messenger-RNA decay (1)
- meta-analysis based orthology (1)
- metabolic adaptation (1)
- metastases (1)
- methanoarchaea (1)
- methanol methyltransferase isozymes (1)
- methanosarcina mazei GO1 (1)
- methicillin (1)
- methionine biosynthesis (1)
- miRNAs (1)
- mice (1)
- microRNAs (1)
- microSPLiT (1)
- microarray (1)
- microbial diversity (1)
- microbial ecology (1)
- microbiology (1)
- microbiome (1)
- microbiota (1)
- microenvironment (1)
- microneme (1)
- microtubule motor (1)
- midgut (1)
- migration (1)
- mikrobielle Diversität (1)
- mikrobielle Ökologie (1)
- mitochondria (1)
- model (1)
- modulation of virus replication (1)
- molecular epidemiology (1)
- molecular evolution (1)
- monocyte (1)
- morphogenesis (1)
- mouse (1)
- mucosal inflammation (1)
- multidrug-resistant bacteria (1)
- multivesicular tubule (1)
- murine leishmaniasis (1)
- mycobacterium tuberculosis (1)
- mycobacterium-tuberculosis (1)
- myelin biology and repair (1)
- myeloma (1)
- natively unstructured protein (1)
- natural antisense transcripts (1)
- natural transformation (1)
- necrosis-factor-alpha (1)
- neisseria gonorrhoeae (1)
- network biology (1)
- nitrogen regulation (1)
- non-aureus staphylococci (1)
- non-coding RNA (1)
- noncoding RNAs (1)
- nondocing RNA (1)
- norovirus (1)
- northern blotting (1)
- nosocomial pathogen (1)
- nucleotide sequence (1)
- nude-mice (1)
- nutrients (1)
- olfactomedin 4 (1)
- oligopeptide transport (1)
- oligopeptides (1)
- oncolytic viral therapy (1)
- oncolytic virus (1)
- one-health approach (1)
- organic farming (1)
- organization (1)
- organohalide respiration (1)
- organoid culture (1)
- organoids (1)
- origin (1)
- orthology (1)
- orthology network (1)
- outbreak (1)
- outer-membrane proteins (1)
- oviedomycin (1)
- oxidative stress (1)
- pangolin (1)
- par-seqFISH (1)
- parallel evolution (1)
- parasexual recombination (1)
- parasite (1)
- parasitology (1)
- paromomycin (1)
- pathogen (1)
- pathogen-associated molecular pattern (1)
- pathogenesis (1)
- pathogenetic organism (1)
- pathogenic bacteria (1)
- pathogenicity island 2 (1)
- pathogenicity islands (1)
- pathotypes (1)
- peptide (1)
- peptide conjugates (1)
- peptide tyrosine tyrosine (PYY) (1)
- peptide tyrosine tyrosine 3-36 (PYY\(_{3-36}\)) (1)
- peptido-glycan associated protein (1)
- permease (1)
- persistence (1)
- persister cells (1)
- phage (1)
- phagocytes (1)
- phagocytosis (1)
- pharmacokinetics (1)
- phased metamorphosis (1)
- phenotypic heterogeneity (1)
- phenotypic microarray (1)
- pheromones (1)
- phosphorylation (1)
- photooxidative stress (1)
- photosynthesis genes (1)
- phototrophic growth (1)
- phylogenetic analysis (1)
- phylogenetic trees (1)
- phytochemicals (1)
- pig farming methods (1)
- plant-made vaccines (1)
- plant-microbe interaction (1)
- plasmid-chromosome crosstalk (1)
- plasmodium (1)
- plastid targeting (1)
- point mutation (1)
- polyadenylation sites (1)
- polycistronic transcription (1)
- polymerase chain reaction (PCR) (1)
- porphyromonas gingivalis (1)
- positive selection (1)
- post-transcriptional regulation (1)
- post-transcriptionalregulation (1)
- posttranscriptional control (1)
- ppl (1)
- pre-messenger RNA (1)
- promastigotes (1)
- promoters (1)
- prophage (1)
- protease (1)
- protein (1)
- protein HFQ (1)
- protein expressions (1)
- protein families database (1)
- protein kinase signaling cascade (1)
- protein synthesis (1)
- protein-RNA recognition (1)
- protozoan parasite (1)
- pseudomas aeruginosa (1)
- pulmonary (1)
- purification (1)
- pyrococcus furiosus (1)
- quanititative proteomics (1)
- quinone (1)
- rRNA depletion (1)
- radiation-therapy (1)
- radioiodine therapy (1)
- ralstonia solanacearum (1)
- rat (1)
- receptor (1)
- receptors (1)
- reciprocal best hit (1)
- recombinant proteins (1)
- regionalization and organoids (1)
- regulation (1)
- regulatory small RNAs (1)
- remote sequence conservation (1)
- replication (1)
- reporter (1)
- reporter genes (1)
- repression (1)
- reputation (1)
- resistance mechanism (1)
- resistance-breaking properties (1)
- resistant Staphylococcus-aureus (1)
- restenosis (1)
- reveals (1)
- rhodobacter sphaeroides (1)
- ribosomal RNA (1)
- rotavirus (1)
- sRNA atlas (1)
- sRNA biogenesis (1)
- salmonella (1)
- salmonella enterica (1)
- sationary phase (1)
- scaffold protein (1)
- schistosoma (1)
- schistosomula (1)
- scholarly publishing (1)
- scientific publishing (1)
- screening (1)
- secondary structure (1)
- segmentation (1)
- sequence motif analysis (1)
- sequences (1)
- sequencing protocol (1)
- serotonin (1)
- serovar Typhimurium (1)
- serum resistance (1)
- sexual stage (1)
- sexual stage surface proteins (1)
- sfaA gene) (1)
- shiga toxin (1)
- shock sigma factor (1)
- siRNAs (1)
- sigma factor (1)
- signal-transduction systems (1)
- simultaneous (1)
- singlet oxygen stress (1)
- sinorhizobium fredii NGR234 (1)
- skin fatty acid (1)
- small interfering RNAs (1)
- small non-coding RNAs (1)
- small noncoding RNAs (1)
- small proteins (1)
- small regulatory RNAs (1)
- sodium-iodide symporter (1)
- solubility (1)
- soluble-RNA (1)
- soluble-RNAs (1)
- sortase A (1)
- specificity (1)
- sponge (1)
- spores (1)
- stability (1)
- stage-i (1)
- staib agar (1)
- staphilococci (1)
- staphylocccal infection/epidemiology (1)
- staphylococcus (1)
- stationary phase (1)
- stomach (1)
- strain (1)
- strain Newman (1)
- streptococcus pneumoniae (1)
- stress resistance (1)
- stress response (1)
- stringency (1)
- structural elucidation (1)
- structural modification (1)
- structure activity (1)
- structure-activity relationship (1)
- structure–activity (1)
- subcellular localization (1)
- subpopulation (1)
- subtilis genome (1)
- sulfates (1)
- sulfur (1)
- suppressor mutation (1)
- surgery (1)
- synthetase (1)
- tag based (1)
- tandem mass-spectra (1)
- target (1)
- target recognition (1)
- tetrachloroethene (1)
- thiostrepton (1)
- thymyl cinnamate (1)
- thyroid-cancer (1)
- tobacco (1)
- toll-like receptor 2 (1)
- topical treatment (1)
- toxin (1)
- trans-activation (1)
- transcription factor (1)
- transcription initiation site (1)
- transcription regulator (1)
- transcription start site (1)
- transcription start sites (1)
- transcriptional control (1)
- transcriptional landscape (1)
- transcriptional regulation (1)
- transcriptional regulator (1)
- transcriptional start site (1)
- transcriptional uni (1)
- transcriptome analysis (1)
- transcriptomeanalysis (1)
- transfection (1)
- transfer (1)
- transfer RNA (1)
- transkiptome (1)
- translation initiation (1)
- translational initiation (1)
- translocation (1)
- transmission blocking vaccine (1)
- transport (1)
- transport systems (1)
- transposable elements (1)
- transposition (1)
- tuberculosis (1)
- two-component systems (1)
- two‐component system (1)
- type III protein secretion system complex (1)
- type III secretion system pathways (1)
- tyrosine kinase (1)
- ubiquitin (1)
- ulcreative colitis (1)
- untranslated regions (1)
- urinary tract infection (1)
- urinary tract infection (UTI) (1)
- urinary-tract-infection (1)
- uropathogenic Escherichia coli (1)
- uropathogenicity (1)
- uropathogens (1)
- vaccine (1)
- vaccines (1)
- vacuole (1)
- vacuoles (1)
- variant surface glycoprotein (1)
- version control (1)
- vertical transmission (1)
- vibrio parahaemolyticus (1)
- viral protein-R (1)
- viral replication (1)
- virotherapy (1)
- virulence genes (1)
- virulence modulation (1)
- virus-infection (1)
- visceral leishmaniasis (1)
- wikis (1)
- workflow platform (1)
- xanthomonas (1)
- xanthomonas campestris (1)
- xanthomonas maltophilia (1)
- yeast (1)
- yvcK/glmR operon (1)
- zinc cluster transcription factor (1)
- zoonotic (1)
- zoonotic risk (1)
- Übertrag (1)
Institute
- Institut für Molekulare Infektionsbiologie (342) (remove)
Sonstige beteiligte Institutionen
- Genelux Corporation, San Diego Science Center, 3030 Bunker Hill Street, Suite 310, San Diego, California 92109, USA (1)
- Helmholtz Center for RNA-based Infection Research (1)
- Institut für Molekulare Infektionsbiologie (MIB) der Universität Würzburg (1)
- MRB Forschungszentrum für Magnet-Resonanz-Bayern e.V., Am Hubland, D-97074 Würzburg (1)
- Research Center for Infectious Diseases (ZINF), University of Wuerzburg, Wuerzburg, Germany, (1)
- Research Center of Infectious Diseases (ZINF) of the University of Wurzburg, Germany (1)
- Universitätsklinikum Münster (1)
- Zentrum für Infektionsforschung (ZINF): Nachwuchsgruppe 2 (1)
Background
Differential RNA-sequencing (dRNA-seq) is indispensable for determination of primary transcriptomes. However, using dRNA-seq data to map transcriptional start sites (TSSs) and promoters genome-wide is a bioinformatics challenge. We performed dRNA-seq of Bradyrhizobium japonicum USDA 110, the nitrogen-fixing symbiont of soybean, and developed algorithms to map TSSs and promoters.
Results
A specialized machine learning procedure for TSS recognition allowed us to map 15,923 TSSs: 14,360 in free-living bacteria, 4329 in symbiosis with soybean and 2766 in both conditions. Further, we provide proteomic evidence for 4090 proteins, among them 107 proteins corresponding to new genes and 178 proteins with N-termini different from the existing annotation (72 and 109 of them with TSS support, respectively). Guided by proteomics evidence, previously identified TSSs and TSSs experimentally validated here, we assign a score threshold to flag 14 % of the mapped TSSs as a class of lower confidence. However, this class of lower confidence contains valid TSSs of low-abundant transcripts. Moreover, we developed a de novo algorithm to identify promoter motifs upstream of mapped TSSs, which is publicly available, and found motifs mainly used in symbiosis (similar to RpoN-dependent promoters) or under both conditions (similar to RpoD-dependent promoters). Mapped TSSs and putative promoters, proteomic evidence and updated gene annotation were combined into an annotation file.
Conclusions
The genome-wide TSS and promoter maps along with the extended genome annotation of B. japonicum represent a valuable resource for future systems biology studies and for detailed analyses of individual non-coding transcripts and ORFs. Our data will also provide new insights into bacterial gene regulation during the agriculturally important symbiosis between rhizobia and legumes.
Microcin C (McC) is a peptide-nucleotide antibiotic produced by Escherichia coli cells harboring a plasmid-borne operon mccABCDE. The heptapeptide MccA is converted into McC by adenylation catalyzed by the MccB enzyme. Since MccA is a substrate for MccB, a mechanism that regulates the MccA/MccB ratio likely exists. Here, we show that transcription from a promoter located upstream of mccA directs the synthesis of two transcripts: a short highly abundant transcript containing the mccA ORF and a longer minor transcript containing mccA and downstream ORFs. The short transcript is generated when RNA polymerase terminates transcription at an intrinsic terminator located in the intergenic region between the mccA and mccB genes. The function of this terminator is strongly attenuated by upstream mcc sequences. Attenuation is relieved and transcription termination is induced when ribosome binds to the mccA ORF. Ribosome binding also makes the mccA RNA exceptionally stable. Together, these two effects-ribosome induced transcription termination and stabilization of the message-account for very high abundance of the mccA transcript that is essential for McC production. The general scheme appears to be evolutionary conserved as ribosome-induced transcription termination also occurs in a homologous operon from Helicobacter pylori.
A total of 36 Escherichia coli urinary tract isolates (UTI) of serotype 06, with different combinations of capsule ( K) and flagellin ( H) antigens, were analysed according to the outer membrane pattern (OMP), serum resistance properties, mannose-resistant hemagglutination using various types of erythrocytes, and also for the genetic presence and the expression of Pfimbriae. S fimbriae/F1 C fimbriae, Type 1 fimbriae, aerobactin and hemolysin. Twenty selected strains were further analysed by pulsed field gel electrophoresis (PFGE), elaborating genomic profilas by Xba I cleavage and subsequent Southern hybridization to virulence-associated DNA probes. lt could be shown that 06 UTI isolates represent a highly heterogeneaus group of strains according to the occurrence and combination of these traits. Relatedness an the genetic and the phenotypic Ievei was found for some of the strains exhibiting the same 0: K: H: F serotype. DNA Iang-range mapping further indicated some interesting features, according to the copy number and the genomic linkage of virulence genes.
Escherichia coli isolates of serotype 06: K5 are the most common causative agents of cystitis and pyelonephritis in adults. To answer the question, as to whether strains of this particular serotype represent one special clonal group, out of a collection of 34 serotype 06: K5 isolates [Zingler et al. ( 1990) Zentralbl. Bakteriol Mikrobiol Hyg [A] 274:372-381] 15 strains were selected andanalyzed in detail. The flagellar (H) antigen and the outer membrane protein (OMP) pattern were determined. Furtherserum resistance properties and the genetic presence and expression of other virulence factors, including hemolysin, aerobactin, P fimbriae, S/F1C fimbriae and type 1 fimbriae was evaluated. In~laddition the Xbalmacrorestriction pattern of ten representative isolates was elaborated and the fimbrial (F) antigentype ofthe P fimbriae was determined, to obtain the complete 0: K: H: F pattern. These analyses could clearly show that the 06: K5 isolates do not represent one clonal group. The Xbal-macrorestriction profiles were heterogeneaus and marked differences in the hybridization patterns, using virulenceassociated gene probes in Southern hybridization of long-range-separated genomic DNA, were observed among the strains. However, some of strains showed similarities in the genomic profiles, arguing for clonal groupings among the 06: K5 isolates. lnterstingly the strains grouped tagether exhibited the same fimbrial F typethat many indicate a coincidence of this phenotypic trait with clonality.
Asymptomatische Bakteriurie (ABU) stellt eine bakterielle Infektion der Harnblase über einen langen Zeitraum dar, die häufig von Escherichia coli hervorgerufen wird, ohne dass typische Symptome einer Harnwegsinfektion auftreten. Um die Charakteristika von ABU E. coli Isolaten genauer zu untersuchen, wurden die Geno- und Phänotypen von 11 ABU-Isolaten verglichen. Außerdem wurden in mehreren aufeinanderfolgenden in vivo-Reisolaten des Modell-ABU Stammes 83972 die Veränderungen im Transkriptom, Proteom und Genom während einer langfristigen Persistenz in der menschlichen Blase charakterisiert. Schließlich wurde der Effekt des menschlichen Wirtes auf die bakterielle Adaptation durch einen Vergleich von in vitro- mit in vivo-kultivierten Stämmen abgeschätzt. ABU-Isolate stellt eine heterogene Gruppe von Organismen dar. Diese können den vier phylogenetischen Hauptgruppen von E. coli sowie unterschiedlichen klonalen Gruppen zugeordnet werden. Dementsprechend unterscheiden sie sich erheblich bezüglich der Zusammensetzung des Genomes, der Genomgröße und auch der Ausstattung mit UPEC-typischen Virulenz-assoziierten Genen. Multi-Lokus-Sequenz-Typisierung legt nahe, dass bestimmte ABU Stämme sich durch Genomreduktion aus UPEC Stämmen entwickelt haben, die eine Harnwegsinfektion mit charakteristischen Symptomen auslösen konnten. Folglich erlaubt die hohe Genomplastizität von E. coli keine generalisierte Betrachtung einzelner Isolate eines Klons. Genomreduktion über Punktmutationen, Genom-Reorganisation und Deletionen resultierte in der Inaktivierung einiger Gene, die für einige UPEC Virulenz-Faktoren kodieren. Dies stützt die Vorstellung, dass eine verminderte bakterielle Aktivierung der Entzündung der Wirtsschleimhaut den Lebensstil von ABU (bei diesen E. coli-)Isolaten fördert. Genregulation und genetische Diversität sind Strategien, die es Bakterien ermöglichen unter sich fortlaufend ändernden Bedingungen zu leben bzw. zu überleben. Um die anpassungsbedingten Veränderungen bei einem langfristigen Wachstum in der Blase zu untersuchen, wurden aufeinanderfolgende Reisolate, denen eine langfristige in vivo-Kolonisierung im menschlichen Wirt beziehungsweise eine in vitro-Kultivierung vorausgegangen ist, im Hinblick auf Veränderungen Genexpression und Genomorganisation analysiert. In diesem Zusammenhang konnte gezeigt werden, dass E. coli in der Lage ist, seine metabolischen Netzwerke verschiedenen Wachstumsbedingungen anzupassen und individuelle bakterielle Kolonisierungsstrategien entwickeln kann. Transkriptom- und Proteom-Analysen zeigten verschiedene metabolische Strategien zur Nährstoffbeschaffung und Energieproduktion bei untersuchten in vivo-Reisolaten vom Stamm 83972, die es ihnen ermöglichen, den Wirt zu kolonisieren. Das Zurückgreifen auf D-Serin, Deoxy- und Ribonucleoside sowie die bidirektionale Umwandlung zwischen Pentose und Glucuronat waren hoch-regulierte Stoffwechselwege, die die in vivo-Reisolate mit zusätzlicher Energie für ein effizientes Wachstum in der Blase versorgen. Zudem wurden in dieser Studie die Netzwerke für eine Reaktion auf Abwehrmechanismen des Wirtes erforscht: Erstmals wurde hier die Rolle der Klasse-III-Alkoholdehydrogenase AdhC, bekannt durch ihre Bedeutung bei der Entgiftung von Stickstoffmonoxid, bei der Wirtsantwort während einer asymptomatischen Bakteriurie gezeigt. Aufeinanderfolgende in vivo- und in vitro-Reisolate vom Stamm 83972 wurden ebenfalls bezüglich ihrer Genomstruktur analysiert. Einige Veränderungen in der Genomstruktur der aufeinanderfolgenden Reisolate, die von einer humanen Kolonisierungsstudie stammen, implizieren die Bedeutung einer Interaktion der Bakterien mit dem Wirt bei der Mikroevolution der Bakterien. Dagegen war die Genomstruktur von Reisolaten eines langfristigen in vitro-Kultivierungsexperiments, bei dem sich der Stamm 83972 ohne Wirtskontakt vermehrt hat, nicht von Veränderungen betroffen. Das legt nahe, dass die Immunantwort eine Genomplastizität fördert und somit eine treibende Kraft für den ABU Lebensstil und die Evolution im Harnwegstrakt ist.
Bacteria lose or gain genetic material and through selection, new variants become fixed in the population. Here we provide the first, genome-wide example of a single bacterial strain’s evolution in different deliberately colonized patients and the surprising insight that hosts appear to personalize their microflora. By first obtaining the complete genome sequence of the prototype asymptomatic bacteriuria strain E. coli 83972 and then resequencing its descendants after therapeutic bladder colonization of different patients, we identified 34 mutations, which affected metabolic and virulence-related genes. Further transcriptome and proteome analysis proved that these genome changes altered bacterial gene expression resulting in unique adaptation patterns in each patient. Our results provide evidence that, in addition to stochastic events, adaptive bacterial evolution is driven by individual host environments. Ongoing loss of gene function supports the hypothesis that evolution towards commensalism rather than virulence is favored during asymptomatic bladder colonization.
To understand the gene regulation of an organism of interest, a comprehensive genome annotation is essential. While some features, such as coding sequences, can be computationally predicted with high accuracy based purely on the genomic sequence, others, such as promoter elements or noncoding RNAs, are harder to detect. RNA sequencing (RNA-seq) has proven to be an efficient method to identify these genomic features and to improve genome annotations. However, processing and integrating RNA-seq data in order to generate high-resolution annotations is challenging, time consuming, and requires numerous steps. We have constructed a powerful and modular tool called ANNOgesic that provides the required analyses and simplifies RNA-seq-based bacterial and archaeal genome annotation. It can integrate data from conventional RNA-seq and differential RNA-seq and predicts and annotates numerous features, including small noncoding RNAs, with high precision. The software is available under an open source license (ISCL) at https://pypi.org/project/ANNOgesic/.
The massive remodeling of the heart tissue, as observed in response to pressure overload or myocardial infarction, is considered to play a causative role in the development of heart failure. Alterations in the heart architecture clearly affect the mechanical properties of the heart muscle, but they are rooted in changes at the cellular level including modulation of gene expression. Together with integrins, the transmembrane receptors linking the extracellular environment to the cytoskeleton, extracellular matrix (ECM) proteins and matricellular proteins are key components of the remodeling process in the heart. Therefore, this thesis was aimed at analysing the role of integrins in the regulation of gene expression and heart muscle performance during cardiac wound repair induced by pressure overload or myocardial infarction (MI). To investigate the contribution of integrin Beta 1, we characterised the response of mice with a conditional, cardiac-specific deletion of the integrin Beta 1 gene in an experimental model of pressure overload by aortic banding (AB). In particular, we measured physiological alterations and gene expression events in the stressed heart in the presence or absence of integrin Beta 1. Interestingly, mice containing a knock-out allele and the ventricular myocyte-specific conditional allele of the integrin Beta 1 gene were born and grew up to adulthood. Though these animals still exhibited minor amounts of integrin Beta1 in the heart (expressed by non-myocytes), these mice displayed abnormal cardiac function and were highly sensitive to AB. Whereas a compensatory hypertrophic response to pressure overload was observed in wildtype mice, the integrin Beta 1-deficient mice were not able to undergo heart tissue remodeling. Furthermore, ECM gene expression was altered and, in particular, the increased expression of the matricellular protein SPARC after AB was abolished in integrin Beta 1–deficient mice. Interestingly, we also found a transient upregulation of SPARC mRNA during heart remodeling after MI using cDNA macroarrays. Indeed, increased SPARC protein levels were observed starting at day 2 (2.55±0.21fold, p<0.01), day 7 (3.72±0.28 fold, p<0.01) and 1 month (1.9±0.16 fold, p<0.01) after MI, which could be abolished by using an integrin alpha v inhibitor in vivo. Immunofluorescence analysis of heart tissue demonstrated that the increased SPARC expression was confined to the infarcted area and occurred together with the influx of fibroblasts into the heart. In vitro, either TGF-Beta 1 or PDGF-BB stimulated SPARC expression by fibroblasts. Inhibition of integrin alpha v did not interfere with TGF-Beta1 or PDGF induced SPARC secretion as determined by ELISA assays or Western blot. However, secretion of TGF-Beta1 and PDGF-BB by cardiomyocytes was induced by vitronectin, a ligand of integrin alpha v, and this response was blocked by the integrin alpga v inhibitor. Functionally, SPARC modulated the migratory response of fibroblasts towards ECM proteins suggesting that the local deposition of SPARC following MI contributes to scar formation. Taken together, our combined in vivo and in vitro data demonstrate that several integrin subunits play critical roles during tissue remodeling in the injured heart. Integrin-dependent gene expression events such as the upregulation of SPARC following MI are critical to orchestrate the healing response. These processes appear to involve complex cross-talk between different cell types such as cardiomyocytes and fibroblasts to allow for locally confined scar formation. The elucidation of the sophisticated interplay between integrins, matricellular proteins such as SPARC, and growth factors will undoubtedly provide us with a better and clinically useful understanding of the molecular mechanisms governing heart remodeling.
Agrobacterium species are capable of interkingdom gene transfer between bacteria and plants. The genome of Agrobacterium tumefaciens consists of a circular and a linear chromosome, the At-plasmid and the Ti-plasmid, which harbors bacterial virulence genes required for tumor formation in plants. Little is known about promoter sequences and the small RNA (sRNA) repertoire of this and other α-proteobacteria. We used a differential RNA sequencing (dRNA-seq) approach to map transcriptional start sites of 388 annotated genes and operons. In addition, a total number of 228 sRNAs was revealed from all four Agrobacterium replicons. Twenty-two of these were confirmed by independent RNA gel blot analysis and several sRNAs were differentially expressed in response to growth media, growth phase, temperature or pH. One sRNA from the Ti-plasmid was massively induced under virulence conditions. The presence of 76 cis-antisense sRNAs, two of them on the reverse strand of virulence genes, suggests considerable antisense transcription in Agrobacterium. The information gained from this study provides a valuable reservoir for an in-depth understanding of sRNA-mediated regulation of the complex physiology and infection process of Agrobacterium.
Motivation:
Next generation sequencing technologies have provided us with a wealth of information on genetic variation, but predi cting the functional significance of this variation is a difficult task. While many comparative genomics studies have focused on gene flux and large scale changes, relatively little attention has been paid to quantifying the effects of single nucleotide polymorphisms and indels on protein function, particularly in bacterial genomics.
Results:
We present a hidden Markov model based approach we call delta-bitscore (DBS) for identifying orthologous proteins that have diverged at the amino acid sequence level in a way that is likely to impact biological function. We benchmark this approach with several widely used datasets and apply it to a proof-of-concept study of orthologous proteomes in an investigation of host adaptation in Salmonella enterica. We highlight the value of the method in identifying functional divergence of genes, and suggest that this tool may be a better approach than the commonly used dN/dS metric for identifying functionally significant genetic changes occurring in recently diverged organisms.
FinO domain proteins such as ProQ of the model pathogen Salmonella enterica have emerged as a new class of major RNA-binding proteins in bacteria. ProQ has been shown to target hundreds of transcripts, including mRNAs from many virulence regions, but its role, if any, in bacterial pathogenesis has not been studied. Here, using a Dual RNA-seq approach to profile ProQ-dependent gene expression changes as Salmonella infects human cells, we reveal dysregulation of bacterial motility, chemotaxis, and virulence genes which is accompanied by altered MAPK (mitogen-activated protein kinase) signaling in the host. Comparison with the other major RNA chaperone in Salmonella, Hfq, reinforces the notion that these two global RNA-binding proteins work in parallel to ensure full virulence. Of newly discovered infection-associated ProQ-bound small noncoding RNAs (sRNAs), we show that the 3′UTR-derived sRNA STnc540 is capable of repressing an infection-induced magnesium transporter mRNA in a ProQ-dependent manner. Together, this comprehensive study uncovers the relevance of ProQ for Salmonella pathogenesis and highlights the importance of RNA-binding proteins in regulating bacterial virulence programs.
IMPORTANCE
The protein ProQ has recently been discovered as the centerpiece of a previously overlooked “third domain” of small RNA-mediated control of gene expression in bacteria. As in vitro work continues to reveal molecular mechanisms, it is also important to understand how ProQ affects the life cycle of bacterial pathogens as these pathogens infect eukaryotic cells. Here, we have determined how ProQ shapes Salmonella virulence and how the activities of this RNA-binding protein compare with those of Hfq, another central protein in RNA-based gene regulation in this and other bacteria. To this end, we apply global transcriptomics of pathogen and host cells during infection. In doing so, we reveal ProQ-dependent transcript changes in key virulence and host immune pathways. Moreover, we differentiate the roles of ProQ from those of Hfq during infection, for both coding and noncoding transcripts, and provide an important resource for those interested in ProQ-dependent small RNAs in enteric bacteria.
The transcriptome is a powerful proxy for the physiological state of a cell, healthy or diseased. As a result, transcriptome analysis has become a key tool in understanding the molecular changes that accompany bacterial infections of eukaryotic cells. Until recently, such transcriptomic studies have been technically limited to analyzing mRNA expression changes in either the bacterial pathogen or the infected eukaryotic host cell. However, the increasing sensitivity of high-throughput RNA sequencing now enables “dual RNA-seq” studies, simultaneously capturing all classes of coding and noncoding transcripts in both the pathogen and the host. In the five years since the concept of dual RNA-seq was introduced, the technique has been applied to a range of infection models. This has not only led to a better understanding of the physiological changes in pathogen and host during the course of an infection but has also revealed hidden molecular phenotypes of virulence-associated small noncoding RNAs that were not visible in standard infection assays. Here, we use the knowledge gained from these recent studies to suggest experimental and computational guidelines for the design of future dual RNA-seq studies. We conclude this review by discussing prospective applications of the technique.
The infection of a eukaryotic host cell by a bacterial pathogen is one of the most intimate examples of cross-kingdom interactions in biology. Infection processes are highly relevant from both a basic research as well as a clinical point of view. Sophisticated mechanisms have evolved in the pathogen to manipulate the host response and vice versa host cells have developed a wide range of anti-microbial defense strategies to combat bacterial invasion and clear infections. However, it is this diversity and complexity that makes infection research so challenging to technically address as common approaches have either been optimized for bacterial or eukaryotic organisms. Instead, methods are required that are able to deal with the often dramatic discrepancy between host and pathogen with respect to various cellular properties and processes. One class of cellular macromolecules that exemplify this host-pathogen heterogeneity is given by their transcriptomes: Bacterial transcripts differ from their eukaryotic counterparts in many aspects that involve both quantitative and qualitative traits. The entity of RNA transcripts present in a cell is of paramount interest as it reflects the cell’s physiological state under the given condition. Genome-wide transcriptomic techniques such as RNA-seq have therefore been used for single-organism analyses for several years, but their applicability has been limited for infection studies.
The present work describes the establishment of a novel transcriptomic approach for infection biology which we have termed “Dual RNA-seq”. Using this technology, it was intended to shed light particularly on the contribution of non-protein-encoding transcripts to virulence, as these classes have mostly evaded previous infection studies due to the lack of suitable methods. The performance of Dual RNA-seq was evaluated in an in vitro infection model based on the important facultative intracellular pathogen Salmonella enterica serovar Typhimurium and different human cell lines. Dual RNA-seq was found to be capable of capturing all major bacterial and human transcript classes and proved reproducible. During the course of these experiments, a previously largely uncharacterized bacterial small non-coding RNA (sRNA), referred to as STnc440, was identified as one of the most strongly induced genes in intracellular Salmonella. Interestingly, while inhibition of STnc440 expression has been previously shown to cause a virulence defect in different animal models of Salmonellosis, the underlying molecular mechanisms have remained obscure. Here, classical genetics, transcriptomics and biochemical assays proposed a complex model of Salmonella gene expression control that is orchestrated by this sRNA. In particular, STnc440 was found to be involved in the regulation of multiple bacterial target mRNAs by direct base pair interaction with consequences for Salmonella virulence and implications for the host’s immune response. These findings exemplify the scope of Dual RNA-seq for the identification and characterization of novel bacterial virulence factors during host infection.
Methionine is the first amino acid of every newly synthesised protein. In combination with its role as precursor for the vital methyl-group donor S-adenosylmethionine, methionine is essential for every living cell. The opportunistic human pathogen Staphylococcus aureus is capable of synthesising methionine de novo, when it becomes scarce in the environment. All genes required for the de novo biosynthesis are encoded by the metICFE-mdh operon, except for metX. Expression is controlled by a hierarchical network with a methionyl-tRNA-specific T-box riboswitch (MET-TBRS) as centrepiece, that is also referred to as met leader (RNA). T-box riboswitches (TBRS) are regulatory RNA elements located in the 5’-untranslated region (5’-UTR) of genes. The effector molecule of T-box riboswitches is uncharged cognate tRNA. The prevailing mechanism of action is premature termination of transcription of the nascent RNA in the absence of the effector (i.e. uncharged cognate tRNA) due to formation of a hairpin structure, the Terminator stem. In presence of the effector, a transient stabilisation of the alternative structure, the Antiterminator, enables transcription of the downstream genes (‘read-through’). Albeit, after the read-through the thermodynamically more stable Terminator eventually forms. The Terminator and the Antiterminator are two mutually exclusive structures. Previous work of the research group showed that in staphylococci the MET-TBRS ensures strictly methionine-dependent control of met operon expression. Uncharged methionyl-tRNA that activates the system is only present in sufficient amounts under methionine-deprived conditions. In contrast to other bacterial TBRS, the staphylococcal MET-TBRS has some characteristic features regarding its length and predicted secondary structure whose relevance for the function are yet unkown.
Aim of the present thesis was to experimentally determine the structure of the met leader RNA and to investigate the stability of the met operon-specific transcripts in the context of methionine biosynthesis control. Furthermore, the yet unknown function of the mdh gene within the met operon was to be determined.
In the context of this thesis, the secondary structure of the met leader was determined employing in-line probing. The structural analysis revealed the presence of almost all highly conserved T-box riboswitch structural characteristics. Furthermore, three additional stems, absent in all T-box riboswitches analysed to date, could be identified. Particularly remarkable is the above average length of the Terminator stem which renders it a potential target of the double-strand-specific endoribonuclease III (RNase III). The RNase III-dependent cleavage of the met leader could be experimentally verified by the use of suitable mutants. Moreover, the exact cleavage site within the Terminator was determined.
The unusual immediate separation of the met leader from the met operon mRNA via the RNase III cleavage within the Terminator stem induces the rapid degradation of the met leader RNA and, most likely, that of the 5’-region of the met mRNA. The met mRNA is degraded from its 5’-end by the exoribonuclease RNase J. The stability of the met mRNA was found to vary over the length of the transcript with an instable 5’-end (metI and metC) and a longer half-life towards the 3’-end (metE and mdh). The varying transcript stability is reflected by differences in the available cellular protein levels. The obtained data suggest that programmed mRNA degradation is another level of regulation in the complex network of staphylococcal de novo methionine biosynthesis control.
In addition, the MET-TBRS was studied with regard to a future use as a drug target for novel antimicrobial agents. To this end, effects of a dysregulated methionine biosynthesis on bacterial growth and survival were investigated in met leader mutants that either caused permanent transcription of the met operon (‘ON’) or prevented operon transcription (‘OFF’), irrespective of the methionine status in the cell. Methionine deprivation turned out to be a strong selection pressure, as ‘OFF’ mutants acquired adaptive mutations within the met leader to restore met operon expression that subsequently re-enabled growth.
The second part of the thesis was dedicated to the characterisation of the Mdh protein that is encoded by the last gene of the met operon and whose function is unknown yet. At first, co-transcription and -expression with the met operon could be demonstrated. Next, the Mdh protein was overexpressed and purified and the crystal structure of Mdh was solved to high resolution by the Kisker research group (Rudolf-Virchow-Zentrum Würzburg). Analysis of the structure revealed the amino acid residues crucial for catalytic activity, and zinc was identified as a co-factor of Mdh. Also, Mdh was shown to exist as a dimer. However, identification of the Mdh substrate was, in the context of this thesis, (still) unsuccessful. Nevertheless, interactions of Mdh with enzymes of the met operon could be demonstrated by employing the bacterial two-hybrid system. This fact and the high conservation of mdh/Mdh on nucleotide and amino acid level among numerous staphylococcal species suggests an important role of Mdh within the methionine metabolism that should be a worthwhile subject of future research.
In Staphylococcus aureus, de novo methionine biosynthesis is regulated by a unique hierarchical pathway involving stringent-response controlled CodY repression in combination with a T-box riboswitch and RNA decay. The T-box riboswitch residing in the 5′ untranslated region (met leader RNA) of the S. aureus metICFE-mdh operon controls downstream gene transcription upon interaction with uncharged methionyl-tRNA. met leader and metICFE-mdh (m)RNAs undergo RNase-mediated degradation in a process whose molecular details are poorly understood. Here we determined the secondary structure of the met leader RNA and found the element to harbor, beyond other conserved T-box riboswitch structural features, a terminator helix which is target for RNase III endoribonucleolytic cleavage. As the terminator is a thermodynamically highly stable structure, it also forms posttranscriptionally in met leader/ metICFE-mdh read-through transcripts. Cleavage by RNase III releases the met leader from metICFE-mdh mRNA and initiates RNase J-mediated degradation of the mRNA from the 5′-end. Of note, metICFE-mdh mRNA stability varies over the length of the transcript with a longer lifespan towards the 3′-end. The obtained data suggest that coordinated RNA decay represents another checkpoint in a complex regulatory network that adjusts costly methionine biosynthesis to current metabolic requirements.
Converging evidence suggests a role of serotonin (5-hydroxytryptamine, 5-HT) and tryptophan hydroxylase 2 (TPH2), the rate-limiting enzyme of 5-HT synthesis in the brain, in modulating long-term, neurobiological effects of early-life adversity. Here, we aimed at further elucidating the molecular mechanisms underlying this interaction, and its consequences for socio-emotional behaviors, with a focus on anxiety and social interaction. In this study, adult, male Tph2 null mutant (Tph2\(^{-/-}\)) and heterozygous (Tph2\(^{+/-}\)) mice, and their wildtype littermates (Tph2\(^{+/+}\)) were exposed to neonatal, maternal separation (MS) and screened for behavioral changes, followed by genome-wide RNA expression and DNA methylation profiling. In Tph2\(^{-/-}\) mice, brain 5-HT deficiency profoundly affected socio-emotional behaviors, i.e., decreased avoidance of the aversive open arms in the elevated plus-maze (EPM) as well as decreased prosocial and increased rule breaking behavior in the resident-intruder test when compared to their wildtype littermates. Tph2\(^{+/-}\) mice showed an ambiguous profile with context-dependent, behavioral responses. In the EPM they showed similar avoidance of the open arm but decreased prosocial and increased rule breaking behavior in the resident-intruder test when compared to their wildtype littermates. Notably, MS effects on behavior were subtle and depended on the Tph2 genotype, in particular increasing the observed avoidance of EPM open arms in wildtype and Tph2\(^{+/-}\) mice when compared to their Tph2\(^{-/-}\) littermates. On the genomic level, the interaction of Tph2 genotype with MS differentially affected the expression of numerous genes, of which a subset showed an overlap with DNA methylation profiles at corresponding loci. Remarkably, changes in methylation nearby and expression of the gene encoding cholecystokinin, which were inversely correlated to each other, were associated with variations in anxiety-related phenotypes. In conclusion, next to various behavioral alterations, we identified gene expression and DNA methylation profiles to be associated with TPH2 inactivation and its interaction with MS, suggesting a gene-by-environment interaction-dependent, modulatory function of brain 5-HT availability.
Background: In principle, the elimination of malignancies by oncolytic virotherapy could proceed by different mechanisms - e.g. tumor cell specific oncolysis, destruction of the tumor vasculature or an anti-tumoral immunological response. In this study, we analyzed the contribution of these factors to elucidate the responsible mechanism for regression of human breast tumor xenografts upon colonization with an attenuated vaccinia virus (VACV). Methods: Breast tumor xenografts were analyzed 6 weeks post VACV infection (p.i.; regression phase) by immunohistochemistry and mouse-specific expression arrays. Viral-mediated oncolysis was determined by tumor growth analysis combined with microscopic studies of intratumoral virus distribution. The tumor vasculature was morphologically characterized by diameter and density measurements and vessel functionality was analyzed by lectin perfusion and extravasation studies. Immunological aspects of viral-mediated tumor regression were studied in either immune-deficient mouse strains (T-, B-, NK-cell-deficient) or upon cyclophosphamide-induced immunosuppression (MHCII+-cell depletion) in nude mice. Results: Late stage VACV-infected breast tumors showed extensive necrosis, which was highly specific to cancer cells. The tumor vasculature in infected tumor areas remained functional and the endothelial cells were not infected. However, viral colonization triggers hyperpermeability and dilatation of the tumor vessels, which resembled the activated endothelium in wounded tissue. Moreover, we demonstrated an increased expression of genes involved in leukocyte-endothelial cell interaction in VACV-infected tumors, which orchestrate perivascular inflammatory cell infiltration. The immunohistochemical analysis of infected tumors displayed intense infiltration of MHCII-positive cells and colocalization of tumor vessels with MHCII+/CD31+ vascular leukocytes. However, GI-101A tumor growth analysis upon VACV-infection in either immunosuppressed nude mice (MHCII+-cell depleted) or in immune-deficient mouse strains (T-, B-, NK-cell-deficient) revealed that neither MHCII-positive immune cells nor T-, B-, or NK cells contributed significantly to VACV-mediated tumor regression. In contrast, tumors of immunosuppressed mice showed enhanced viral spreading and tumor necrosis. Conclusions: Taken together, these results indicate that VACV-mediated oncolysis is the primary mechanism of tumor shrinkage in the late regression phase. Neither the destruction of the tumor vasculature nor the massive VACV-mediated intratumoral inflammation was a prerequisite for tumor regression. We propose that approaches to enhance viral replication and spread within the tumor microenvironment should improve therapeutical outcome.
Background
Oncolytic virotherapy of tumors is an up-coming, promising therapeutic modality of cancer therapy. Unfortunately, non-invasive techniques to evaluate the inflammatory host response to treatment are rare. Here, we evaluate \(^{19}\)F magnetic resonance imaging (MRI) which enables the non-invasive visualization of inflammatory processes in pathological conditions by the use of perfluorocarbon nanoemulsions (PFC) for monitoring of oncolytic virotherapy.
Methodology/Principal Findings
The Vaccinia virus strain GLV-1h68 was used as an oncolytic agent for the treatment of different tumor models. Systemic application of PFC emulsions followed by \(^1H\)/\(^{19}\)F MRI of mock-infected and GLV-1h68-infected tumor-bearing mice revealed a significant accumulation of the \(^{19}\)F signal in the tumor rim of virus-treated mice. Histological examination of tumors confirmed a similar spatial distribution of the \(^{19}\)F signal hot spots and \(CD68^+\)-macrophages. Thereby, the \(CD68^+\)-macrophages encapsulate the GFP-positive viral infection foci. In multiple tumor models, we specifically visualized early inflammatory cell recruitment in Vaccinia virus colonized tumors. Furthermore, we documented that the \(^{19}\)F signal correlated with the extent of viral spreading within tumors.
Conclusions/Significance
These results suggest \(^{19}\)F MRI as a non-invasive methodology to document the tumor-associated host immune response as well as the extent of intratumoral viral replication. Thus, \(^{19}\)F MRI represents a new platform to non-invasively investigate the role of the host immune response for therapeutic outcome of oncolytic virotherapy and individual patient response.
Background: Recent data suggest that cancer stem cells (CSCs) play an important role in cancer, as these cells possess enhanced tumor-forming capabilities and are responsible for relapses after apparently curative therapies have been undertaken. Hence, novel cancer therapies will be needed to test for both tumor regression and CSC targeting. The use of oncolytic vaccinia virus (VACV) represents an attractive anti-tumor approach and is currently under evaluation in clinical trials. The purpose of this study was to demonstrate whether VACV does kill CSCs that are resistant to irradiation and chemotherapy.
Methods: Cancer stem-like cells were identified and separated from the human breast cancer cell line GI-101A by virtue of increased aldehyde dehydrogenase 1 (ALDH1) activity as assessed by the ALDEFLUOR assay and cancer stem cell-like features such as chemo-resistance, irradiation-resistance and tumor-initiating were confirmed in cell culture and in animal models. VACV treatments were applied to both ALDEFLUOR-positive cells in cell culture and in xenograft tumors derived from these cells. Moreover, we identified and isolated CD44\(^+\)CD24\(^+\)ESA\(^+\) cells from GI-101A upon an epithelial-mesenchymal transition (EMT). These cells were similarly characterized both in cell culture and in animal models.
Results: We demonstrated for the first time that the oncolytic VACV GLV-1h68 strain replicated more efficiently in cells with higher ALDH1 activity that possessed stem cell-like features than in cells with lower ALDH1 activity. GLV-1h68 selectively colonized and eventually eradicated xenograft tumors originating from cells with higher ALDH1 activity. Furthermore, GLV-1h68 also showed preferential replication in CD44\(^+\)CD24\(^+\)ESA\(^+\) cells derived from GI-101A upon an EMT induction as well as in xenograft tumors originating from these cells that were more tumorigenic than CD44\(^+\)CD24\(^-\)ESA\(^+\) cells.
Conclusions: Taken together, our findings indicate that GLV-1h68 efficiently replicates and kills cancer stem-like cells. Thus, GLV-1h68 may become a promising agent for eradicating both primary and metastatic tumors, especially tumors harboring cancer stem-like cells that are resistant to chemo and/or radiotherapy and may be responsible for recurrence of tumors.
Epstein-Barr virus (EBV) is best known for infection of B cells, in which it usually establishes an asymptomatic lifelong infection, but is also associated with the development of multiple B cell lymphomas. EBV also infects epithelial cells and is associated with all cases of undifferentiated nasopharyngeal carcinoma (NPC). EBV is etiologically linked with at least 8% of gastric cancer (EBVaGC) that comprises a genetically and epigenetically distinct subset of GC. Although we have a very good understanding of B cell entry and lymphomagenesis, the sequence of events leading to EBVaGC remains poorly understood. Recently, ephrin receptor A2 (EPHA2) was proposed as the epithelial cell receptor on human cancer cell lines. Although we confirm some of these results, we demonstrate that EBV does not infect healthy adult stem cell-derived gastric organoids. In matched pairs of normal and cancer-derived organoids from the same patient, EBV only reproducibly infected the cancer organoids. While there was no clear pattern of differential expression between normal and cancer organoids for EPHA2 at the RNA and protein level, the subcellular location of the protein differed markedly. Confocal microscopy showed EPHA2 localization at the cell-cell junctions in primary cells, but not in cancer cell lines. Furthermore, histologic analysis of patient tissue revealed the absence of EBV in healthy epithelium and presence of EBV in epithelial cells from inflamed tissue. These data suggest that the EPHA2 receptor is not accessible to EBV on healthy gastric epithelial cells with intact cell-cell contacts, but either this or another, yet to be identified receptor may become accessible following cellular changes induced by inflammation or transformation, rendering changes in the cellular architecture an essential prerequisite to EBV infection.
Background: Searching the orthologs of a given protein or DNA sequence is one of the most important and most commonly used Bioinformatics methods in Biology. Programs like BLAST or the orthology search engine Inparanoid can be used to find orthologs when the similarity between two sequences is sufficiently high. They however fail when the level of conservation is low. The detection of remotely conserved proteins oftentimes involves sophisticated manual intervention that is difficult to automate.
Results: Here, we introduce morFeus, a search program to find remotely conserved orthologs. Based on relaxed sequence similarity searches, morFeus selects sequences based on the similarity of their alignments to the query, tests for orthology by iterative reciprocal BLAST searches and calculates a network score for the resulting network of orthologs that is a measure of orthology independent of the E-value. Detecting remotely conserved orthologs of a protein using morFeus thus requires no manual intervention. We demonstrate the performance of morFeus by comparing it to state-of-the-art orthology resources and methods. We provide an example of remotely conserved orthologs, which were experimentally shown to be functionally equivalent in the respective organisms and therefore meet the criteria of the orthology-function conjecture.
Conclusions: Based on our results, we conclude that morFeus is a powerful and specific search method for detecting remotely conserved orthologs.
Background
During development in human erythrocytes, Plasmodium falciparum parasites display a remarkable number of adhesive proteins on their plasma membrane. In the invasive merozoites, these include members of the PfMSP1 and PfAMA1/RON complexes, which facilitate contact between merozoites and red blood cells. In gametocytes, sexual precursor cells mediating parasite transmission to the mosquito vector, plasma membrane-associated proteins primarily belong to the PfCCp and 6-cys families with roles in fertilization. This study describes a newly identified WD40-repeat protein unique to Plasmodium species that associates with adhesion protein complexes of both merozoites and gametocytes.
Methods
The WD40-repeat protein-like protein PfWLP1 was identified via co-immunoprecipitation assays followed by mass spectrometry and characterized using biochemical and immunohistochemistry methods. Reverse genetics were employed for functional analysis.
Results
PfWLP1 is expressed both in schizonts and gametocytes. In mature schizonts, the protein localizes underneath the merozoite micronemes and interacts with PfAMA1, while in gametocytes PfWLP1 primarily accumulates underneath the plasma membrane and associates with PfCCp1 and Pfs230. Reverse genetics failed to disrupt the pfwlp1 gene, while haemagglutinin-tagging was feasible, suggesting a crucial function for PfWLP1 during blood stage replication.
Conclusions
This is the first report on a plasmodial WD40-repeat protein associating with cell adhesion proteins. Since WD40 domains are known to mediate protein–protein contact by serving as a rigid scaffold for protein interactions, the presented data suggest that PfWLP1 supports the stability of adhesion protein complexes of the plasmodial blood stages.
Our body is colonized by a vast array of bacteria the sum of which forms our microbiota. The gut alone harbors >1,000 bacterial species. An understanding of their individual or synergistic contributions to human health and disease demands means to interfere with their functions on the species level. Most of the currently available antibiotics are broad‐spectrum, thus too unspecific for a selective depletion of a single species of interest from the microbiota. Programmable RNA antibiotics in the form of short antisense oligonucleotides (ASOs) promise to achieve precision manipulation of bacterial communities. These ASOs are coupled to small peptides that carry them inside the bacteria to silence mRNAs of essential genes, for example, to target antibiotic‐resistant pathogens as an alternative to standard antibiotics. There is already proof‐of‐principle with diverse bacteria, but many open questions remain with respect to true species specificity, potential off‐targeting, choice of peptides for delivery, bacterial resistance mechanisms and the host response. While there is unlikely a one‐fits‐all solution for all microbiome species, I will discuss how recent progress in bacterial RNA biology may help to accelerate the development of programmable RNA antibiotics for microbiome editing and other applications.
Small proteins, often defined as shorter than 50 amino acids, have been implicated
in fundamental cellular processes. Despite this, they have been largely understudied throughout all domains of life, since their size often makes their identification and characterization challenging.
This work addressed the knowledge gap surrounding small proteins with a focus
on the model bacterial pathogen Salmonella Typhimurium. In a first step,
new small proteins were identified with a combination of computational and experimental approaches. Infection-relevant datasets were then investigated with
the updated Salmonella annotation to prioritize promising candidates involved in virulence.
To implement the annotation of new small proteins, predictions from the algorithm
sPepFinder were merged with those derived from Ribo-seq. These were added to the Salmonella annotation and used to (re)analyse different datasets. Information
regarding expression during infection (dual RNA-seq) and requirement for virulence (TraDIS) was collected for each given coding sequence. In parallel,
Grad-seq data were mined to identify small proteins engaged in intermolecular
interactions.
The combination of dual RNA-seq and TraDIS lead to the identification of small
proteins with features of virulence factors, namely high intracellular induction
and a virulence phenotype upon transposon insertion. As a proof of principle of
the power of this approach in highlighting high confidence candidates, two small
proteins were characterized in the context of Salmonella infection.
MgrB, a known regulator of the PhoPQ two-component system, was shown to be essential for the infection of epithelial cells and macrophages, possibly via its stabilizing effect on flagella or by interacting with other sensor kinases of twocomponent
systems. YjiS, so far uncharacterized in Salmonella, had an opposite role in infection, with its deletion rendering Salmonella hypervirulent. The mechanism underlying this, though still obscure, likely relies on the interaction with
inner-membrane proteins.
Overall, this work provides a global description of Salmonella small proteins in
the context of infection with a combinatorial approach that expedites the identification
of interesting candidates. Different high-throughput datasets available for
a broad range of organisms can be analysed in a similar manner with a focus on small proteins. This will lead to the identification of key factors in the regulation
of various processes, thus for example providing targets for the treatment of bacterial
infections or, in the case of commensal bacteria, for the modulation of the microbiota composition.
We investigated the roJe of Escherichia coU expressing mannose-resistant hemagglutination and adhesins with regard to the induction of leukotrienes from a suspension of human lymphocytes, monocytes, and basophils (LMBs) compared with human polymorphonuclear granulocytes (PMNs). Genetically cloned E. coli strains expressing various types of mannose-resistant hemagglutination (MRH+) were phagocytosed to a higher degree by monocytes than the nonadherent E. coli strain. The various strains dUfered in their capacity to induce a chemiluminescence response, which showed the same pattern for LMBs and PMNs. Stimulation of LMBs with bacteria alone, unlike granulocytes, did not activate the cells for the release of leukotrienes. However, preincubation of LMBs with bacteria decreased subsequent leukotriene formation when the cells were stimulated with calcium ionophore. The inhibitory eft'ect was dependent on the concentration of bacteria used for preincubation as weil as on the preincubation temperature. The various bacterial strains dift'ered in inhibitory potency for mediator release. Preincubation of LMBs with zymosan, opsonized zymosan, the bacterfal peptide FMLP, and peptidoglycan bad no inhibitory eft'ect or even increased subsequent IeukotrieDe formation. Opsonized bacteria were far less inhibitory than nonopsonized bacteria. In contrast to human LMBs, preincubation of human PMNs with mannose-resistant bacteria led to increased leukotriene 84 generation and reduced w-oxidation of leukotriene 84 • Our data soggest that phagocytes (neutrophils, monocytes) respond in a different way for leukotriene formation after Interaction with mannose-resistant E. coli.
The eukaryotic unicellular pathogen Plasmodium falciparum tightly regulates gene expression, both during development and in adaptation to dynamic host environments. This regulation is evident in the mutually exclusive expression of members of clonally variant virulence multigene families. While epigenetic regulators have been selectively identified at active or repressed virulence genes, their specific recruitment remains a mystery. In recent years, noncoding RNAs (ncRNAs) have emerged as lynchpins of eukaryotic gene regulation; by binding to epigenetic regulators, they provide target specificity to otherwise non-specific enzyme complexes. Not surprisingly, there is great interest in understanding the role of ncRNA in P. falciparum, in particular, their contribution to the mutually exclusive expression of virulence genes. The current repertoire of P. falciparum ncRNAs includes, but is not limited to, subtelomeric ncRNAs, virulence gene-associated ncRNAs and natural antisense RNA transcripts. Continued improvement in high-throughput sequencing methods is sure to expand this repertoire. Here, we summarize recent advances in P. falciparum ncRNA biology, with an emphasis on ncRNA-mediated epigenetic modes of gene regulation.
The prevention of restenosis after percutaneous coronary intervention is a major task for researchers and clinicians in cardiovascular pharmacology. Nearly 1.5 million PTCA are performed every year worldwide and, due to the implantation of stents, most of the cases can be treated successfully. 60% of those patients develop restenosis within 6 months. SMC migration and ECM deposition are known to be responsible for neointima formation. Among many processes, integrin initiated signalling events play a central role in SMC migration. Many integrins recognize a specific RGD sequence which is present in several ECM proteins and cell surface immunoglobulin super family molecules. Until now, there are various integrin antagonists such as antibodies, cyclic peptides, peptidomimetics, and non-peptides have been shown to interfere with such pathological situations indicating the importance of integrin initiated signalling pathways in SMC migration. Therefore, in this study SMC migration induced by ECM proteins was inhibited either using pharmacological inhibitor or by overexpressing the endogenous inhibitor of FAK by AAV vector system. In the first part of the thesis, the effect of integrin-ligand stimulation on hCASMCs was studied. The tyrosine phosphorylation of many cellular proteins was observed from serum starved hCASMCs replated on VN but not on PL coated plates. The major tyrosine phosphorylated protein was identified as FAK by immunoprecipitation and also phosphorylation was found at Tyr 397, the autophosphorylation site of FAK. Further, VN induced the dose dependent migration of hCASMCs in haptotaxis assay. The integrin v inhibitor was used to block those ECM stimulated integrin signalling pathways and cell migration. It inhibited the ECM stimulated tyrosine phosphorylation in a dose dependent manner. Interestingly, specific potent antagonism of integrin v abrogated both ECM induced haptotaxis and growth factor induced chemotaxis. The inhibition of migration is consistent with the replating assay results that show interference with integrin induced signalling pathways particularly the FAK tyrosine phosphorylation. The integrin v inhibitor also is able to interfere with hCASMC invasion through matrigel by reducing MMP-2 secretion. Importantly, integrin v inhibitor did not induce the apoptosis in hCASMCs. FAK is a key player in many cellular events and its involvement in cell migration was extensively studied in various cell types. The present study explored the function of FAK in hCASMC migration by overexpression of FRNK, the C-terminal domain of FAK. Overexpression of FRNK inhibited the in vitro SMC migration as well as the neointima formation in a porcine restenosis model in vivo. The last part of this thesis focused on the identification of putative binding partners for the N-terminal domain of FAK by bacterial two-hybrid screen. One of the interesting binding partners was a putative protein of 17.9 kDa. Its human homolog is AGS4, which acts as a GTPase activator. The preliminary results revealed that it is able to interact with N-FAK domain and its expression is high in haematopoietic cells. Taken together the above results suggest that integrin v and FAK are promising targets for inhibition of SMC migration. Disruption of FAK-mediated signalling pathways by a pharmacological inhibitor or by overexpression of FRNK, which acts as dominant-negative regulator, resulted in decreased migration of SMCs and thus can lead to reduction of neointima formation.
F 1 C fimbriae allow uropathogenic Escherichia coli to adhere to specific epithelial surfaces. This adhesive property is probably due to the presence of minor fimbrial components in F1C fimbriae. The foe gene cluster encoding F1C fimbriae has been cloned, as described previously. Here we present the nucleotide sequence (2081 bp) coding for the F 1 C minor fimbria I subunits. The structural genes code for polypeptides of 175 (FocF), 166 (FocG), and 300 (FocH) amino acids. The deduced amino acids of the F 1 C minor subunits were compared with the reported sequences of the minor subunits of other types of fimbriae. The data show that the Foc minor subunits are highly homologous to the corresponding Sfa proteins, whereas homology to the minor subunits of type 1 and P fimbriae is much lower.
As multidrug-resistant bacteria represent a concerning burden, experts insist on the need for a dramatic rethinking on antibiotic use and development in order to avoid a post-antibiotic era. New and rapidly developable strategies for antimicrobial substances, in particular substances highly potent against multidrug-resistant bacteria, are urgently required. Some of the treatment options currently available for multidrug-resistant bacteria are considerably limited by side effects and unfavorable pharmacokinetics. The glycopeptide vancomycin is considered an antibiotic of last resort. Its use is challenged by bacterial strains exhibiting various types of resistance. Therefore, in this study, highly active polycationic peptide-vancomycin conjugates with varying linker characteristics or the addition of PEG moieties were synthesized to optimize pharmacokinetics while retaining or even increasing antimicrobial activity in comparison to vancomycin. The antimicrobial activity of the novel conjugates was determined by microdilution assays on susceptible and vancomycin-resistant bacterial strains. VAN1 and VAN2, the most promising linker-modified derivatives, were further characterized in vivo with molecular imaging and biodistribution studies in rodents, showing that the linker moiety influences both antimicrobial activity and pharmacokinetics. Encouragingly, VAN2 was able to undercut the resistance breakpoint in microdilution assays on vanB and vanC vancomycin-resistant enterococci. Out of all PEGylated derivatives, VAN:PEG1 and VAN:PEG3 were able to overcome vanC resistance. Biodistribution studies of the novel derivatives revealed significant changes in pharmacokinetics when compared with vancomycin. In conclusion, linker modification of vancomycin-polycationic peptide conjugates represents a promising strategy for the modulation of pharmacokinetic behavior while providing potent antimicrobial activity.
Multidrug‐resistant bacteria represent one of the biggest challenges facing modern medicine. The increasing prevalence of glycopeptide resistance compromises the efficacy of vancomycin, for a long time considered as the last resort for the treatment of resistant bacteria. To reestablish its activity, polycationic peptides were conjugated to vancomycin. By site‐specific conjugation, derivatives that bear the peptide moiety at four different sites of the antibiotic were synthesized. The most potent compounds exhibited an approximately 1000‐fold increased antimicrobial activity and were able to overcome the most important types of vancomycin resistance. Additional blocking experiments using d‐Ala‐d‐Ala revealed a mode of action beyond inhibition of cell‐wall formation. The antimicrobial potential of the lead candidate FU002 for bacterial infection treatments could be demonstrated in an in vivo study. Molecular imaging and biodistribution studies revealed that conjugation engenders superior pharmacokinetics.
Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) loci are found in bacterial and archaeal genomes where they provide the molecular machinery for acquisition of immunity against foreign DNA. In addition to the cas genes fundamentally required for CRISPR activity, a second class of genes is associated with the CRISPR loci, of which many have no reported function in CRISPR-mediated immunity. Here, we characterize MM_0565 associated to the type I-B CRISPR-locus of Methanosarcina mazei Gö1. We show that purified MM_0565 composed of a CRISPR-Cas Associated Rossmann Fold (CARF) and a winged helix-turn-helix domain forms a dimer in solution; in vivo, the dimeric MM_0565 is strongly stabilized under high salt stress. While direct effects on CRISPR-Cas transcription were not detected by genetic approaches, specific binding of MM_0565 to the leader region of both CRISPR-Cas systems was observed by microscale thermophoresis and electromobility shift assays. Moreover, overexpression of MM_0565 strongly induced transcription of the cas1-solo gene located in the recently reported casposon, the gene product of which shows high similarity to classical Cas1 proteins. Based on our findings, and taking the absence of the expressed CRISPR locus-encoded Cas1 protein into account, we hypothesize that MM_0565 might modulate the activity of the CRISPR systems on different levels.
Escherichia coli 0139: K82: H1 strains originating from outbreaks and single cases of oedema disease in pigs were characterized by their genomic restriction fragment length polymorphism (RFLP), their virulence pattern, and by the occurrence as well as the genomic distribution of the determinants for hemolysin (hly) and verotoxins (shiga-like toxins; sltI, sltII). Whereas the RFLPs revealed considerable variation among the E. coli 0139: K82: H1 isolates depending the origin and epidemic source of the strains, the virulence gene slt II was found to be present in nearly all strains in a particular chromosomal region. Similar to RFLPs, the plasmid profiles are useful for epidemiological analysis.
According to the hygiene hypothesis, the exposure to infectious agents in early childhood prevents the development of allergen-specific Th2 immune responses because it establishes Th1-based immunity or alternatively, induces the generation of T regulatory cells. Based on this theory, the present study pretended to identify promising microorganism-derived vaccine candidates against allergic asthma in the murine model. In the first part of this work, the efficacy of four different known Th1-inducing adjuvants, i.e. live BCG, heat-killed BCG, CpG and PPD, as components of vaccines aimed at inhibiting allergic asthma was compared. All the adjuvants were effective in inhibiting the development of allergen-induced airway eosinophilia, mucus production, and with the exception of PPD also airway hyperreactivity (AHR), when they were applied together with OVA/alum. Suppression of airway eosinophilia was not observed in IFN-gamma- or IL-12-deficient mice (hk-BCG, CpG-ODN and PPD). Interestingly, live BCG was still able to suppress allergen-induced Th2 responses in the absence of either IFN-gamma or IL-12. The effect of live BCG was also independent on IL-10-, TLR-2-, TLR-4- or MyD88-mediated signaling. When mice vaccinated with the different adjuvants together with OVA/alum were subjected to a second period of OVA/alum immunization, only live and hk-BCG were able to efficiently suppress the development of airway inflammation. This effect could be adoptively transferred by CD4+ T cells. Taken together our data suggest that live BCG>>hk-BCG>CpG>PPD are effective in suppressing allergen-induced Th2 responses. Secondly, the evaluation of a dendritic cell-based vaccination strategy leading to the induction of allergen-specific Th1 cells to protect against the development of allergen-specific Th2 responses was performed. The application of OVA-pulsed BM-DC maturated with CpG was unable to reduce airway eosinophilia and inflammation in OVA-immunized mice. OVA-specific IgG1 or IgE serum levels were also not reduced. The experiments using LC pulsed with OVA yielded similar results. However, the mice vaccinated with CpG/OVA pulsed BM-DC had greatly enhanced levels of OVA-specific IgG2a in the serum, suggesting the induction of allergen-specific Th1 responses in vivo. Thus, these data suggest that the vaccination of mice with OVA-pulsed BM-DC matured with CpG or OVA-pulsed LC did not result in a reduction of allergen-specific Th2 responses in a murine model of severe atopic asthma. Lastly, NES, an excretory/secretory product derived from the helminth Nippostrongylus brasiliensis was evaluated as a new potential adjuvant to prevent the development of allergic responses. The application of NES together with OVA/alum greatly inhibited the development of airway eosinophilia, airway goblet cell metaplasia and mucus production and the development of airway hyperreactivity after metacholine challenge. Furthermore, OVA-specific IgG1 and IgE levels in the serum were also strongly reduced. NES preparations contained small amounts of endotoxin, which may explain these results. However, the suppressive effects of NES on the development of allergen-specific Th2 responses was independent upon IFN-gamma or TLR-4 and still observed in mice treated with LPS-depleted NES. NES reduced OVA-induced Th2 responses also in a IL-10-independent manner. In addition, the digestion with proteinase K or the heat-treatment of NES did not abolish its ability to inhibit allergen-induced Th2 responses. Interestingly, NES suppress OVA-specific Th2 responses in vivo in the presence of a strong NES-specific Th2 environment. Taken together our results suggest that the helminth N. brasiliensis secretes substances which interfere with the development of allergic Th2 responses. In summary, distinct substances derived from microorganisms or helminths which may be used as potential adjuvants to prevent the development of allergic Th2 responses were identified. These findings contribute to the design of efficient vaccines protecting humans from developing allergic asthma.
Ten monoclonal antibodies (McAbs) raised to Schistosoma japonicum eggs could be assigned using several serological and immunochemical techniques to 3 groups. The McAbs, termed A, B and C-McAbs, apparently recognize carbohydrate epitopes that can be located on the same antigen molecule. The antibodies, generally of IgM isotype, are idiotypically related. They are distinct from another IgM McAb (Group D-McAb) the carbohydrate target epitope of which can also be associated with the epitopes of A. B and C-McAbs. The McAbs produce large vacuolated bleb reactions in the circumoval precipitin test (COPT) and target epitopes have different representations in various life cycle stages such as immature and mature eggs, male and female worms (including S. mansoni). Antigens affinity purified on columns containing A, B, C and D-McAbs stimulate proliferation of T cells from egg-sensitized mice and elicit DTH reactions in such mice. This raises the possibility that the target antigens of these carbohydrate-reactive monoclonal antibodies are immunopathologic and involved in egg-induced granuloma formation.
Many pathogenic bacteria utilize specialized secretion systems to deliver proteins called effectors into eukaryotic cells for manipulation of host pathways. The vast majority of known effector targets are host proteins, whereas a potential targeting of host nucleic acids remains little explored. There is only one family of effectors known to target DNA directly, and effectors binding host RNA are unknown. Here, we take a two-pronged approach to search for RNA-binding effectors, combining biocomputational prediction of RNA-binding domains (RBDs) in a newly assembled comprehensive dataset of bacterial secreted proteins, and experimental screening for RNA binding in mammalian cells. Only a small subset of effectors were predicted to carry an RBD, indicating that if RNA targeting was common, it would likely involve new types of RBDs. Our experimental evaluation of effectors with predicted RBDs further argues for a general paucity of RNA binding activities amongst bacterial effectors. We obtained evidence that PipB2 and Lpg2844, effector proteins of Salmonella and Legionella species, respectively, may harbor novel biochemical activities. Our study presenting the first systematic evaluation of the RNA-targeting potential of bacterial effectors offers a basis for discussion of whether or not host RNA is a prominent target of secreted bacterial proteins.
Background: Gametogenesis and fertilization play crucial roles in malaria transmission. While male gametes are thought to be amongst the simplest eukaryotic cells and are proven targets of transmission blocking immunity, little is known about their molecular organization. For example, the pathway of energy metabolism that power motility, a feature that facilitates gamete encounter and fertilization, is unknown.
Methods: Plasmodium berghei microgametes were purified and analysed by whole-cell proteomic analysis for the first time. Data are available via ProteomeXchange with identifier PXD001163.
Results: 615 proteins were recovered, they included all male gamete proteins described thus far. Amongst them were the 11 enzymes of the glycolytic pathway. The hexose transporter was localized to the gamete plasma membrane and it was shown that microgamete motility can be suppressed effectively by inhibitors of this transporter and of the glycolytic pathway.
Conclusions: This study describes the first whole-cell proteomic analysis of the malaria male gamete. It identifies glycolysis as the likely exclusive source of energy for flagellar beat, and provides new insights in original features of Plasmodium flagellar organization.
Background
Malignant pleural effusion (MPE) is associated with advanced stages of lung cancer and is mainly dependent on invasion of the pleura and expression of vascular endothelial growth factor (VEGF) by cancer cells. As MPE indicates an incurable disease with limited palliative treatment options and poor outcome, there is an urgent need for new and efficient treatment options.
Methods
In this study, we used subcutaneously generated PC14PE6 lung adenocarcinoma xenografts in athymic mice that developed subcutaneous malignant effusions (ME) which mimic pleural effusions of the orthotopic model. Using this approach monitoring of therapeutic intervention was facilitated by direct observation of subcutaneous ME formation without the need of sacrificing mice or special imaging equipment as in case of MPE. Further, we tested oncolytic virotherapy using Vaccinia virus as a novel treatment modality against ME in this subcutaneous PC14PE6 xenograft model of advanced lung adenocarcinoma.
Results
We demonstrated significant therapeutic efficacy of Vaccinia virus treatment of both advanced lung adenocarcinoma and tumor-associated ME. We attribute the efficacy to the virus-mediated reduction of tumor cell-derived VEGF levels in tumors, decreased invasion of tumor cells into the peritumoral tissue, and to viral infection of the blood vessel-invading tumor cells. Moreover, we showed that the use of oncolytic Vaccinia virus encoding for a single-chain antibody (scAb) against VEGF (GLAF-1) significantly enhanced mono-therapy of oncolytic treatment.
Conclusions
Here, we demonstrate for the first time that oncolytic virotherapy using tumor-specific Vaccinia virus represents a novel and promising treatment modality for therapy of ME associated with advanced lung cancer.
Bacterial small RNAs (sRNAs) are widespread post-transcriptional regulators that control bacterial stress responses and virulence. Nevertheless, little is known about how they arise and evolve. Homologs can be difficult to identify beyond the strain level using sequence-based approaches, and similar functionalities can arise by convergent evolution. Here, we found that the virulence-associated CJnc190 sRNA of the foodborne pathogen Campylobacter jejuni resembles the RepG sRNA from the gastric pathogen Helicobacter pylori. However, while both sRNAs bind G-rich sites in their target mRNAs using a C/U-rich loop, they largely differ in their biogenesis. RepG is transcribed from a stand-alone gene and does not require processing, whereas CJnc190 is transcribed from two promoters as precursors that are processed by RNase III and also has a cis-encoded antagonist, CJnc180. By comparing CJnc190 homologs in diverse Campylobacter species, we show that RNase III-dependent processing of CJnc190 appears to be a conserved feature even outside of C. jejuni. We also demonstrate the CJnc180 antisense partner is expressed in C. coli, yet here might be derived from the 3’UTR (untranslated region) of an upstream flagella-related gene. Our analysis of G-tract targeting sRNAs in Epsilonproteobacteria demonstrates that similar sRNAs can have markedly different biogenesis pathways.
Analysis of host microRNA function uncovers a role for miR-29b-2-5p in Shigella capture by filopodia
(2017)
MicroRNAs play an important role in the interplay between bacterial pathogens and host cells, participating as host defense mechanisms, as well as exploited by bacteria to subvert host cellular functions. Here, we show that microRNAs modulate infection by Shigella flexneri, a major causative agent of bacillary dysentery in humans. Specifically, we characterize the dual regulatory role of miR-29b-2-5p during infection, showing that this microRNA strongly favors Shigella infection by promoting both bacterial binding to host cells and intracellular replication. Using a combination of transcriptome analysis and targeted high-content RNAi screening, we identify UNC5C as a direct target of miR-29b-2-5p and show its pivotal role in the modulation of Shigella binding to host cells. MiR-29b-2-5p, through repression of UNC5C, strongly enhances filopodia formation thus increasing Shigella capture and promoting bacterial invasion. The increase of filopodia formation mediated by miR-29b-2-5p is dependent on RhoF and Cdc42 Rho-GTPases. Interestingly, the levels of miR-29b-2-5p, but not of other mature microRNAs from the same precursor, are decreased upon Shigella replication at late times post-infection, through degradation of the mature microRNA by the exonuclease PNPT1. While the relatively high basal levels of miR-29b-2-5p at the start of infection ensure efficient Shigella capture by host cell filopodia, dampening of miR-29b-2-5p levels later during infection may constitute a bacterial strategy to favor a balanced intracellular replication to avoid premature cell death and favor dissemination to neighboring cells, or alternatively, part of the host response to counteract Shigella infection. Overall, these findings reveal a previously unappreciated role of microRNAs, and in particular miR-29b-2-5p, in the interaction of Shigella with host cells.
Staphylococcus aureus is a major human pathogen, which can invade and survive in non-professional and professional phagocytes. Uptake by host cells is thought to contribute to pathogenicity and persistence of the bacterium. Upon internalization by epithelial cells, cytotoxic S. aureus strains can escape from the phagosome, replicate in the cytosol and induce host cell death. Here, we identified a staphylococcal cysteine protease to induce cell death after translocation of intracellular S. aureus into the host cell cytoplasm. We demonstrated that loss of staphopain A function leads to delayed onset of host cell death and prolonged intracellular replication of S. aureus in epithelial cells. Overexpression of staphopain A in a non-cytotoxic strain facilitated intracellular killing of the host cell even in the absence of detectable intracellular replication. Moreover, staphopain A contributed to efficient colonization of the lung in a mouse pneumonia model. In phagocytic cells, where intracellular S. aureus is exclusively localized in the phagosome, staphopain A did not contribute to cytotoxicity. Our study suggests that staphopain A is utilized by S. aureus to exit the epithelial host cell and thus contributes to tissue destruction and dissemination of infection.
Author summary Staphylococcus aureus is an antibiotic-resistant pathogen that emerges in hospital and community settings and can cause a variety of diseases ranging from skin abscesses to lung inflammation and blood poisoning. The bacterium can asymptomatically colonize the upper respiratory tract and skin of humans and take advantage of opportune conditions, like immunodeficiency or breached barriers, to cause infection. Although S. aureus was not regarded as intracellular bacterium, it can be internalized by human cells and subsequently exit the host cells by induction of cell death, which is considered to cause tissue destruction and spread of infection. The bacterial virulence factors and underlying molecular mechanisms involved in the intracellular lifestyle of S. aureus remain largely unknown. We identified a bacterial cysteine protease to contribute to host cell death of epithelial cells mediated by intracellular S. aureus. Staphopain A induced killing of the host cell after translocation of the pathogen into the cell cytosol, while bacterial proliferation was not required. Further, the protease enhanced survival of the pathogen during lung infection. These findings reveal a novel, intracellular role for the bacterial protease staphopain A.
Non-aureus staphylococci (NAS) are ubiquitous bacteria in livestock-associated environments where they may act as reservoirs of antimicrobial resistance (AMR) genes for pathogens such as Staphylococcus aureus. Here, we tested whether housing conditions in pig farms could influence the overall AMR-NAS burden. Two hundred and forty porcine commensal and environmental NAS isolates from three different farm types (conventional, alternative, and organic) were tested for phenotypic antimicrobial susceptibility and subjected to whole genome sequencing. Genomic data were analysed regarding species identity and AMR gene carriage. Seventeen different NAS species were identified across all farm types. In contrast to conventional farms, no AMR genes were detectable towards methicillin, aminoglycosides, and phenicols in organic farms. Additionally, AMR genes to macrolides and tetracycline were rare among NAS in organic farms, while such genes were common in conventional husbandries. No differences in AMR detection existed between farm types regarding fosfomycin, lincosamides, fusidic acid, and heavy metal resistance gene presence. The combined data show that husbandry conditions influence the occurrence of resistant and multidrug-resistant bacteria in livestock, suggesting that changing husbandry practices may be an appropriate means of limiting the spread of AMR bacteria on farms.
The sexual phase of Plasmodium falciparum begins with the differentiation of intraerythrocytic sexual stages, termed gametocytes, in the human host. Mature gametocytes circulate in the peripheral blood and are taken up by the mosquito during the blood meal. These stages are essential for the spread of the malaria disease and form gametes in the mosquito midgut within minutes. A highly conserved family of six secreted proteins has been identified in Plasmodium falciparum. They comprise multiple adhesive domains and are termed PfCCp1 through PfCCp5, and PfFNPA. It was revealed in this work that PfCCp multi-domain adhesion proteins form protein complexes in gametocytes and on the surface of newly emerged macrogametes by adhesion domain-mediated binding. Co-Immunoprecipitation assays with activated gametocyte lysates show interactions between PfCCp proteins and indicate surface association via Pfs230 and Pfs25. Pfs230 is connected with the plasma membrane of the parasite by its interaction partner Pfs48/45. This protein is linked to the plasma membrane by a GPI anchor and presumably retains the multi-protein complex on the surface of newly emerged macrogametes in the mosquito midgut. A WD40 domain containing protein was identified to be part of this protein complex. It might serve as platform for the assembly of the multi protein complex or mediate the interplay among proteins, as suggested from known functions of the WD40 domain repeats. During egress from the host erythrocyte, the emerging gametes become vulnerable to factors of the human complement, which is taken up with the blood meal. In this thesis it was found that the complement system is active for about one hour post feeding. Macrogametes defend against complement-mediated lysis by co-opting the human complement regulators Factor H and FHL-1 from the blood-meal. These serum proteins bind via its SCR domains 5-7 to the surface of macrogametes. Once bound, they trigger complement inactivation of the alternative pathway, which prevents induction of complement lysis on the surface of the malaria parasite. Antibodies against Factor H are able to impair the sexual development in vitro and are able to block transmission to the mosquito. Interaction studies on endogenous proteins and immobilized recombinant proteins revealed the PfGAP50 protein as binding partner of Factor H and FHL-1. This protein was hitherto described as a glideosome-associated protein in invasive parasite stages, but has not yet been characterized in gametes. First localization studies indicate a relocation of PfGAP50 from the inner membrane complex to the surface of macrogametes. Malaria still persists as one of the deadliest infectious diseases worldwide. Investigations on the essential transmissive stages, gametocytes and gametes of Plasmodium falciparum, stood in the background of research for a long time. This work deciphered details on protein interactions on the surface of the malaria parasite and provides first information about coactions between the parasite and the human complement in the mosquito midgut.
H-Y-specific and H-2Db-restricted, Lyt-1 "2+ T-cell clones (CTLL) with graded specific cytotoxic activities on male C57BL/6 (B6) target cells (1E3, +++; 2C5, ++; 2A5, +, 3E6, ±) were tested for their capacity to inhibit the generation of H-Y-specific cytotoxic T lymphocytes (CTL) in vitro. Addition of irradiated lymphocytes of CTLL 1E3 and CTLL 3E6 but not those of CTLL 2A5 or CTLL 2C5 abolished the generation of CTL from in vivo primed H-Y-specific precursor cells (CTLP) when added to fresh mixed-lymphocyte cultures (MLC). Exogenous sources of T-cell growth factors (TCGF) did not overcome suppression. Rather the presence of TCGF resulted in a further enhancement of suppressive activities in CTLL 1E3 and 3E6 and the induction of similar activities in cells from CTLL 2A5 and 2C5, which by themselves were not inhibitory. Moreover when added to similar MLC on Day 1 instead of Day 0, only irradiated cells of CTLL 3E6 but not those of the other three CTLL were suppressive. Induction of suppressive activities in H-Y-specific CTLL was independent of the appropriate male stimulator cells since it was also observed in MLC induced by irrelevant antigens (H-2, trinitrophenol). Furthermore at low cell numbers, irradiated lymphocytes from any of the CTLL consistently enhanced CTL activities generated from H-Y-specific CTLP. This augmenting activity, which was not TCGF, could be transferred by soluble mediators present in antigen-sensitized CTLL cultures. Thus, these data indicate (i) that cytotoxic effector cells can function as suppressor cells in the generation of CTL, (ii) that the cytotoxic activity of cloned CTL does not correlate with their capacity to suppress CTL responses, (iii) that the inhibition of CTL responses by CTLL is not due to simple consumption of T-cell growth factors produced in MLC, and (iv) that different CTL clones may interfere with the generation of CTL at different stages of their maturation. Moreover, the experiments suggest an antigen-independent enhancement of suppression by the interaction of CTL with lymphokines. Together with the augmenting activity evoked by cloned CTL the data provide strong evidence for the expression of multiple immunological functions by one particular subset of T cells and suggest that cytotoxic effector cells can differentially regulate the maturation and/or clonal expression of their precursor cells.
In this study we report that cloned Thy-l +, L3T4-, Lyt-l-, Lyt-2+, H-Y-specific and H-2Db-restricted cytotoxic T ce11 lines (CTLL) when indueed by lectin or antigen secrete a soluble mediator(s) (SF) that inhibits proliferation and generation of cytotoxic lymphocytes (CTL) in mixed lymphocyte cultures (MLC). The biological activity was separable by gel filtration and appeared as a broad peak in the moleeular mass range between 10000 and 50000 kDa. It was found that the suppressive activity released by CTLL neither strictly correlates with their cytotoxic potential nor with their ability to produce immune interferon or Iymphotoxin. SF was shown to elicitits activity in an antigen-nonspeeific manner in that it suppressed the maturation of T lymphocytes responding to both, the appropriate H-Y antigen as weH as to unrelated H_2d alloantigens or to the hapten 2,4,6-trinitrophenyl (TNP). The effect of SF on CTL responses was most pronounced in early phases of primary or secondary MLC. When analyzed for its inhibitory activity on precursor ceHs in populations selected for either Lyt-2- or L3T4- lymphocytes, it was found that SF interfered with the maturation of both subsets. The inhibition of CTL responses elicited by SF could not be reversed by the addition of exogenous interleukin 2. The findtng that SF also inhi. bited the proliferation of some but not a11 antigen-dependent cloned T ceHs with helper or eytc'toxic potential provides evidence that the faetor also may regulate effector lymphl)cytes. In addition, the results support the assumption that SF exerts its effect direetly on the responder rather than the stimulator population, and demonstrate that the development of CTL from their preeursor eeHs is contro11ed at least in part by the eytotoxic effeetor cells themselves via a soluble factor(s) that interferes with distinct stages of T ce11 maturation. These findings again emphasize the expression of multiple functions by CTL and indieate their possible role du ring the course of an immune response by their capability to eliminate target cells and to secrete a soluble product(s) that mediates feedback contro!.
Background
Advances in high-throughput sequencing have led to the discovery of widespread transcription of natural antisense transcripts (NATs) in a large number of organisms, where these transcripts have been shown to play important roles in the regulation of gene expression. Likewise, the existence of NATs has been observed in Plasmodium but our understanding towards their genome-wide distribution remains incomplete due to the limited depth and uncertainties in the level of strand specificity of previous datasets.
Results
To gain insights into the genome-wide distribution of NATs in P. falciparum, we performed RNA-ligation based strand-specific RNA sequencing at unprecedented depth. Our data indicate that 78.3% of the genome is transcribed during blood-stage development. Moreover, our analysis reveals significant levels of antisense transcription from at least 24% of protein-coding genes and that while expression levels of NATs change during the intraerythrocytic developmental cycle (IDC), they do not correlate with the corresponding mRNA levels. Interestingly, antisense transcription is not evenly distributed across coding regions (CDSs) but strongly clustered towards the 3′-end of CDSs. Furthermore, for a significant subset of NATs, transcript levels correlate with mRNA levels of neighboring genes.
Finally, we were able to identify the polyadenylation sites (PASs) for a subset of NATs, demonstrating that at least some NATs are polyadenylated. We also mapped the PASs of 3443 coding genes, yielding an average 3′ untranslated region length of 523 bp.
Conclusions
Our strand-specific analysis of the P. falciparum transcriptome expands and strengthens the existing body of evidence that antisense transcription is a substantial phenomenon in P. falciparum. For a subset of neighboring genes we find that sense and antisense transcript levels are intricately linked while other NATs appear to be regulated independently of mRNA transcription. Our deep strand-specific dataset will provide a valuable resource for the precise determination of expression levels as it separates sense from antisense transcript levels, which we find to often significantly differ. In addition, the extensive novel data on 3′ UTR length will allow others to perform searches for regulatory motifs in the UTRs and help understand post-translational regulation in P. falciparum.
Campylobacter jejuni is currently the leading cause of bacterial gastroenteritis in humans. Comparison of multiple Campylobacter strains revealed a high genetic and phenotypic diversity. However, little is known about differences in transcriptome organization, gene expression, and small RNA (sRNA) repertoires. Here we present the first comparative primary transcriptome analysis based on the differential RNA–seq (dRNA–seq) of four C. jejuni isolates. Our approach includes a novel, generic method for the automated annotation of transcriptional start sites (TSS), which allowed us to provide genome-wide promoter maps in the analyzed strains. These global TSS maps are refined through the integration of a SuperGenome approach that allows for a comparative TSS annotation by mapping RNA–seq data of multiple strains into a common coordinate system derived from a whole-genome alignment. Considering the steadily increasing amount of RNA–seq studies, our automated TSS annotation will not only facilitate transcriptome annotation for a wider range of pro- and eukaryotes but can also be adapted for the analysis among different growth or stress conditions. Our comparative dRNA–seq analysis revealed conservation of most TSS, but also single-nucleotide-polymorphisms (SNP) in promoter regions, which lead to strain-specific transcriptional output. Furthermore, we identified strain-specific sRNA repertoires that could contribute to differential gene regulation among strains. In addition, we identified a novel minimal CRISPR-system in Campylobacter of the type-II CRISPR subtype, which relies on the host factor RNase III and a trans-encoded sRNA for maturation of crRNAs. This minimal system of Campylobacter, which seems active in only some strains, employs a unique maturation pathway, since the crRNAs are transcribed from individual promoters in the upstream repeats and thereby minimize the requirements for the maturation machinery. Overall, our study provides new insights into strain-specific transcriptome organization and sRNAs, and reveals genes that could modulate phenotypic variation among strains despite high conservation at the DNA level.
RNA-binding proteins (RBPs) have been established as core components of several post-transcriptional gene regulation mechanisms. Experimental techniques such as cross-linking and co-immunoprecipitation have enabled the identification of RBPs, RNA-binding domains (RBDs) and their regulatory roles in the eukaryotic species such as human and yeast in large-scale. In contrast, our knowledge of the number and potential diversity of RBPs in bacteria is poorer due to the technical challenges associated with the existing global screening approaches. We introduce APRICOT, a computational pipeline for the sequence-based identification and characterization of proteins using RBDs known from experimental studies. The pipeline identifies functional motifs in protein sequences using position-specific scoring matrices and Hidden Markov Models of the functional domains and statistically scores them based on a series of sequence-based features. Subsequently, APRICOT identifies putative RBPs and characterizes them by several biological properties. Here we demonstrate the application and adaptability of the pipeline on large-scale protein sets, including the bacterial proteome of Escherichia coli. APRICOT showed better performance on various datasets compared to other existing tools for the sequence-based prediction of RBPs by achieving an average sensitivity and specificity of 0.90 and 0.91 respectively. The command-line tool and its documentation are available at https://pypi.python.org/pypi/bio-apricot.
RNA-binding proteins (RBPs) have been extensively studied in eukaryotes, where they post-transcriptionally regulate many cellular events including RNA transport, translation, and stability. Experimental techniques, such as cross-linking and co-purification followed by either mass spectrometry or RNA sequencing has enabled the identification and characterization of RBPs, their conserved RNA-binding domains (RBDs), and the regulatory roles of these proteins on a genome-wide scale. These developments in quantitative, high-resolution, and high-throughput screening techniques have greatly expanded our understanding of RBPs in human and yeast cells. In contrast, our knowledge of number and potential diversity of RBPs in bacteria is comparatively poor, in part due to the technical challenges associated with existing global screening approaches developed in eukaryotes.
Genome- and proteome-wide screening approaches performed in silico may circumvent these technical issues to obtain a broad picture of the RNA interactome of bacteria and identify strong RBP candidates for more detailed experimental study. Here, I report APRICOT (“Analyzing Protein RNA Interaction by Combined Output Technique”), a computational pipeline for the sequence-based identification and characterization of candidate RNA-binding proteins encoded in the genomes of all domains of life using RBDs known from experimental studies. The pipeline identifies functional motifs in protein sequences of an input proteome using position-specific scoring matrices and hidden Markov models of all conserved domains available in the databases and then statistically score them based on a series of sequence-based features. Subsequently, APRICOT identifies putative RBPs and characterizes them according to functionally relevant structural properties. APRICOT performed better than other existing tools for the sequence-based prediction on the known RBP data sets. The applications and adaptability of the software was demonstrated on several large bacterial RBP data sets including the complete proteome of Salmonella Typhimurium strain SL1344. APRICOT reported 1068 Salmonella proteins as RBP candidates, which were subsequently categorized using the RBDs that have been reported in both eukaryotic and bacterial proteins. A set of 131 strong RBP candidates was selected for experimental confirmation and characterization of RNA-binding activity using RNA co-immunoprecipitation followed by high-throughput sequencing (RIP-Seq) experiments. Based on the relative abundance of transcripts across the RIP-Seq libraries, a catalogue of enriched genes was established for each candidate, which shows the RNA-binding potential of 90% of these proteins. Furthermore, the direct targets of few of these putative RBPs were validated by means of cross-linking and co-immunoprecipitation (CLIP) experiments.
This thesis presents the computational pipeline APRICOT for the global screening of protein primary sequences for potential RBPs in bacteria using RBD information from all kingdoms of life. Furthermore, it provides the first bio-computational resource of putative RBPs in Salmonella, which could now be further studied for their biological and regulatory roles. The command line tool and its documentation are available at https://malvikasharan.github.io/APRICOT/.